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1. INTRODUCTION 
1.1 AIMS AND OBJECTIVES 
Steroidal drugs hormones and other biologically active 
steroids possess pronounced and specific biological activities. 
These steroids play important role in metabolism and therapeutics. 
The knowledge of properties of these steroids stimulated us to 
Intensify research on their synthetic modifications. Cholesterol 
molecule is the basic skeleton of all steroidal drugs and hormones 
of natural and synthetic origin. Synthetic drugs have been prepared 
by doing modification in the structure of natural steroidal molecule 
or alteration in the basic cholesterol nucleus. It involves the 
Introduction of hetero atom at various sites in steroidal nucleus 
(Pettit and Kasturi, 1961); (Jacob and Brown field, 1960). This 
alteration is always aimed to enhance the selectively of these new 
derivatives in certain parameters of their biological activity. 
Laboratories of Indian Universities engaged in steroidal 
research are not highly sophisticated. Poor infrastructure of these 
labs is capable of incorporating hetero atoms only up to ring B In 
the cholesterol molecule, while most of the industrially prepared 
steroidal drugs available in the market have been produced by 
doing modification in ring C and D This industrial process has 
been done in highly sophisticated and expensive set up Our study 
IS based for the sake of economy and to search more effective new 
steroidal drugs so that the economically cheaper production could 
result in more effective steroidal drugs and hormones 
To fulfill this aspiration an attempt has been made to test 
some less complicated easily synthesized cholesterol derivatives, 
reported in the past. While exposing these derivatives on albino 
rats' brain exclusive and elaborative biochemical, pharmacological 
behavioral and histopathological studies have tobe conducted. 
Steroids used in this study are : (i) 3-p-acetoxy-cholest-5-ene (ii) 
3-(^acetoxy-6-nitro-cholest-5-ene (iii)3(l-acetoxy-5a-cholestan-
6-one. 
Literature lacks such type of previous studies or trial of 
these derivatives for the search of new steroidal drugs. Present 
research work Is aimed to achieve this motive, work done in this 
study is based on the facts described below 
Steroid are known to possess maximum receptors in the 
central nervous system CNS of all vertebrates is highly enriched 
in various lipids (Suzuki, 1981). They play vital role in both the 
structure and function of neural membrane These lipids are 
metabollcally very active and thus their functional significance 
should not be overlooked. Studies on lipid profile in the CNS forms 
an important part of neurobiochemical investigations. 
Present research work is confined only up to the critical 
biochemical evaluation of total lipid and lipid fraction in major 
brain parts of albino rat (cerebrum, cerebellum, brain stem, spinal 
cord) Our second motive is to obtain detailed critical data based 
on structure activity co-relationship of cholesterol derivatives 
taken for trial 
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2. REVIEW OF LITERATURE 
2.1 STEROIDS 
Steroids are widely distributed in nature and play an important 
role in the vital activities of living organisms. The family of 
steroidal substances is critically important to plant and animal 
life. The first steroidal compound "Cholesterol" v\/as reported as 
early as 1812 by ME . Chervenl. Cholesterol is the chief sterol of 
mammalian tissue and obligate precursor of steroidal hormones 
and bile salts. The dramatic expansion of steroidal chemistry 
came with the discovery of sex hormones in 1929-35. Biologically 
important steroids include the adrenal hormones, the sex hormones, 
(plants and animal sterols,) corticosteroids and hydrocortisones. 
Steroidal hormones and other biologically active steroids possess 
pronounced and specific biological activities. These steroids play 
important role in metabolism and therapeutics. The knowledge of 
the these steroids stimulated researchers to intensify research on 
their synthetic modifications. 
A large number of hetero steroids have been synthesized 
and screened for their chemical biological, therapeutic and 
industrial potentials Modification is done by substituting 
uncommon substituent (hetero atom) at different positions at 
unusual carbon frame work of steroids. It resulted either in decrease 
or increase in certain biological and physiological properties 
(Jacob and Brown field, 1960); (Doorenbosand WIr, 1961); (Pettit 
and Kasturi, 1961); (Letter and Knof. 1960). 
Adrenal glands produce steroids hormones, which are 
physiologically significant to our body. Destruction diseases of 
adrenal gland results in then deficiency of adrenal steroids. 
Symptoms in such cases could be studied as a symbol of deficiency 
of adrenal steroids. Addison (1855) was the first scientist who first 
time studied such clinical syndromes resulting from the destruction 
disease of adrenal glands. These experiments inspired to Brown 
Sequrad (1856) to do the pioneering experiments on the effects of 
adrenoiactomy and concluded that "adrenal glands are essential to 
life" 
By the third decade of this century it was generally recognized 
that the cortex rather then the medulla is the life maintaining 
portion of the gland. The complex nature of adrenocortical 
deficiency was dramatized in 1930s by the partisan character of 
research groups oriented to study either the imbalance of 
electrolytes or the defects in carbohydrate metabolism present in 
the deficient state. Renal loss of Na* was convincingly 
demonstrated to be a characteristic of adrenocortical insufficiency 
by Harrop and associates (1933) as well as by Loeb and Coworkers 
(Loeb, 1933). Equally convincing was the demonstration of a 
depletionof carbohydrate stores (Coriet al., 1927). Furthermore, 
Hypoglycemia could be corrected by adrenocortical extracts 
(Britton & Siwette, 1931). Glucose and glycogen formed under 
influence of the adrenal cortex during fasting appeared to be 
derived from tissue protein (Long et al. 1940). From these studies 
emerged the concepts of the two types of adrenocortical hormones. 
The mineralocorticoids which primarily regulate electrolyte 
homeostasis and the glucocorticoids which are concerned with 
carbohydrate metabolism. This concept of dichotomy of salt and 
sugar hormones (mineralocorticoids and glucocorticoids) has 
proved useful survives at the present time in modified form. In 
1932, the neurosurgeon Gushing described the syndrome of 
hypercorticlsm bear his name (Gushing 1932). The cases Gushing 
described were those of pituitary basopohilism, recognized 
subsequently to be a consequence of hypersecretion of ACTH 
The preparation of adrenocortical extracts with a reasonable 
degree of activity was first accomplished in 1930. By 1942, 
organic chemists had isolated crystallized and elucidated the 
structures of 28 steroids from the adrenal cortex (Reichstein et. ai 
1943). Five of these compounds Cortisol (Hydrocortisone, 
cortisone, corticosterone, 11- dehydrocorticosterone. and 11-
desoxycosterone)were demonstrated to be biologically active 
Another decade passed before the principal mineralocorticoids 
was discovered In 1950.Deming and Leutscher made an attempt 
to find the principal active material he discovered that the extracts 
of urine from patients with edema induced Na* retention and K* 
excretion in adrenolactomized rats. The definitive evidence for 
the source ofthe active material was provided byTaitet. al. (1952) 
who purified the compound with this activity from adrenocortical 
extracts. The substance was crystallized, the structure was 
established and the hormones was named aldosterone (Simpson 
et. al. 1954). 
In this same era the role of abenohypophysis was being 
elucidated by other investigator's The classical studies of Foster 
& Smith 1926 established the fact that hypophysectomy result m 
atrophy of the adrenal cortex. By 1933 it had been demonstrated 
that cell-free extracts of the anterior pituitary has a stimulating 
effect upon the adrenal cortex of the hypopysectomized animal 
Further chemical fractionation of such extracts led to the isolation 
of a hormone, ACTH, that acted selectively to cause chemical and 
morphological changes in the adrenal cortex (Astwood et al., 
1952),Its structure was established by Beel et al.(1956). The rate 
of release of ACTH from adenohypopysis was shown to be 
determined by the balance of the Inhibitory effects of the hormones 
of the adrenal cortex and the excitatory effects of the nervous 
system. (Ingle et al., 1938). 
A detailed analysis of the morphology of the adrenal cortex 
by Swan (1940) and Deane and Greep (1946) suggested that the 
specific function of zonaglumerulosa is to autonomously 
elaborating a hormone regulated electrolyte balance. This hormone 
is now known to be aldosterone. 
Prolonged administration of sexual adrenocortical and 
thyroid hormones produces a feedback reaction causing diminished 
secretion of the corresponding glandotrophic hormones and also 
bring about morphological changes, These changes could be 
seen histologically discernible in the glandular parenchyma of the 
adenohypopysis. In a similar manner, protracted administration of 
posterior-lobe hormones leads to noticeable morphological 
adaptive reaction in the magnocellular hypothalamus 
neurohypophyseal system (ORF- 1966). On the basis of these 
empirical finding it was thus conjectured that long term application 
of anterior lobe hormones would bring about morphological 
changes in the paracellular hypothalamic nuclei controlling 
adenohypophyseal activity (ORF-1969). 
In 1949, Hench demonstrated the effects of cortisone and 
ACTH In the treatment of rheumatoid arthritis. As early as 1929 
Hench had been impressed by the fact that arthritic patients when 
pregnant or jaundiced, experienced a temporary remission, he 
believed that a metabolite was responsible for the remission. The 
possibility that the antirheumatic substance might be an 
adrenocortical hormone was entertained and as soon as cortisone 
was available It was tested In a case acute rheumatoid arthritis. 
Fortunately an adequate dose was employed and the response 
was dramatic Thereafter the detailed salutary effects of ACTH 
were also demonstrated by Hench, (1949). The Noble Prize in 
medicine was jointly awarded to Kendall and Reichstein (who 
were responsible for much of the basic chemical research that led 
to the synthesis of the steroid) and to Hench, whose contribution 
has just been described 
According to the British Medical Association reports (1968 
on therapeutic abortion cited in the famous Modies book of 
Medical Jurisprudence and Toxicology, long-term exposure of 
oral progestrins, androgens and estrogens causes foetal 
abnormality". The Medical Termination of Pregnancy Act. 1971 
also legalize the abortion of the pregnant women^ treated with 
steroidal drugs like cortisone or oral contraceptives (Reddy N . 
1995). 
Contrary to above report recent study reveals that antenatal 
corticosteroids given for a short period (24 hr and 1 week before 
birth) reduces respiratory distress syndrome, neonatal mortality 
by about 50% with comparable reduction in necrotismg 
enterocolitis. 
The benefits of antenatal corticosteroids are likely to 
outweigh any possible disadvantage due to maternal or neonatal 
in fect ions There is no evidence of major adverse 
neurodevelopmental outcome in later childhood among infants of 
treated mothers (Crov^ley 1994). Due to this protective effect 
academic and professional bodies have recommended that with 
very few contra-indications^ the use of antenatal corticosteroids 
may be considered in women likely to deliver prematurely (Royal 
Collegemeet 1993,NIH 1995). Since these are the most effective 
single strategy for reducing the adverse consequences of preterm 
birth (Scottish Neonatal consultants study, 1996). 
Steroidal therapy has been used extensively in head injury 
Its effectiveness has documented in the work of. Reulen et al., 
(1972). Taupel et al (1976). Various high potency glucocorticoids, 
chiefly dexamethasone have been used widely in the management 
of intracranial hypertension and brain edema. Use of these steroids 
may dramatically and rapidly reduces the focal and general signs 
of brain tumor (Faci,1976). 
It has been confirmed by recent studies that combined oral 
contraceptive improve in the both acne and hirsutum (Fotherby, 
1995). 
11 
Role of parathyroid hormones and dihydrolachysterol is 
established in the reduction of lead toxicity from the bone. These 
hormones mobilize Lead from the skeleton and augment the 
concentration of Leadin blood and the rats of its excretion in urine 
(Cutis D., 1990). 
In cases of delayed neuropathy caused by organophosphorus 
compounds, treatment with corticoid in such cases modify it. for 
example delayed neuropathy caused by tri-ortho-tolyl phosphate 
<TOTP), but the same treatment could not showed protective 
effect in the case of o-o-Di-isopropyl phosphorofluoridate (DFP) 
Induced delayed neurotoxicity. It is because due to the intrinsic 
differences between the organophosphorus compound DFP and 
TOTP (Ehrich. M; et al 1985). 
Sex linked factors have been found to affect rheumatoid 
arthritis (RA) and multiple sclerosis (MS) in a similar way but both 
diseases are slightly more common among women than men 
(Duquette et. al, 1992). During pregency, in particular during the 
last trimester condition of both RA and MS tend to become better 
but again become painful in postpartum (Davis and Maslow, 
1992) Reason behind these changes are complex. Sex hormones. 
12 
sex chromosomes or sex determined neuroendocrine factors 
many be involved here (Hazes et al.,1990b) Collaegen induced 
arthritis (CIA) and experimental autoimmune encephalomyelitis 
(EAE) are different models and affect different target organs but 
they are both dependent on autoaggressive T-cells. Studies have 
proved that estrogens suppressess the pregency induced EAE 
and the collagen induced arthritis in mice (Liselotte Jansson et al, 
1996). 
A lot of artificially synthesized hormones are being used in 
the general treatment, such as NS-3, an analogue of Thyrotropin-
Releasing Hormone (Itoh et al, 1995). Attempts are being done 
to produce safer and more effective steroids by modifying their 
structure or incorporating them with other drugs (Suhail. 1991). 
Synthetic glucocorticoids are widely used therapeutically 
for their immunosuppressive and antiinflammatory effects 
(Kathurina et. al, 1994).Use of the adrenal steroids exert opposite 
effects on the immune system in the mammalians. (Fraschini F. et 
aL 1990). 
Allauddin and Mertin - Smith (1962), Martin - Smith Surgue 
(1964) have critically reviewed the biological activities in steroids 
possessing N-atom both of natural and synthetic origin. 
13 
At present steroidal drugs are the only drugs which fall 
under the category of life saving drugs These drugs are used m 
highest medical emergency to save the life of millions of sufferer 
every day. Steroidal drugs are commonly used on the occasions 
where generally any other non-steroidal drugs fail to produce any 
curable effect. 
A lot of research work have been done in the field of hetero 
steroidal synthesis. Their identification has been done by their 
characterization, chemical and spectral studies, for example oxa-
steroids (containing NHO functional group) Ahmad et al.,(1984) 
Aza-steroids (containing Nitrogen) Mushfiq and Nadeem Iqbal. 
(1986), Ahmad et al.^(1985), Keto-Steroids (containing ketone) 
Rao Owais, (1993). 
Steroidal drugs have been used for a wide range ofdiseases. 
for example, they are used as antiviral (Awasthi et al.>1982). 
antiallergic (Honma.et al., 1982). anticonvulsant (Ahmad, and 
Shukia, 1983), antiulcer (Otssuka, 1982). analgesic (Fognet et 
al* 1983), antifungal (Awasthi, 1982), antihypertensive (Ahmad 
1983), antifertility (Islam et al., 1983), antidepressant (Fancois, 
et al.,1918), nerve exciting (Takenchi, et al.J981), antimineralo 
14 
FIG.-2.1 
CHOLESTEROL 
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(Ralph et al. 1985). a^-Dacterial (Sail et a i .J986i fungicidal 
(Saitoet al 1986), antithyroid (Grudzinshi et ai. 197S Ikeda. and 
Soga, 1978), Shibata i et al. 1986) and growth inhibitor (Birgit 
1980), in cardiac diseases (Wundewald et al.,1985): in skin 
disorders and as inflanmation inhibitors (Annen Klaus et al., 
1985). 
The most alarnnmg international problem of population "^ ut 
burst is being tackled by steroidal drugs Even though a lot of 
alternate non-steroidal drugs devices and methods have been 
invented to avoid the conception.still steroidal drugs are the first 
and favorite choice among the family planners 
2.2 CHEMISTRY AND GENERAL STRUCTURE OF 
CHOLESTEROL 
Cholesterol is present in all eukeryotes as free or as fatty 
esters, particularly in the brain and spinal cord of vertebrates It 
was first isolated from njman gall stones The mam sources of 
cholesterol are fish-live- oil. brain and spinal cord of catties 
Cholesterol is a v,riite crystalline v^hich is optically active-
The structure o* cholesterol was elucidated by Wieland. 
16 
Windvas and their coworkers (1903-1932). The established 
structure of cholesterol is given here. It shows the method of 
numbering 
The Molecule (Fig 1) consist of a side-chain and a nucleus 
which is composed of four rings, designated A, B, C and D, 
beginning from the six-membered ring on the left. It should be 
noted that the nucleus contains two angular methyl groups, one at 
C-10 other at C-13. There is a side chain of CgH^^ at the C-17 
position (I). 
2.3 METABOLISM OF STEROIDAL HORMONES IN BRAIN-
TISSUE : 
When the steroid hormones interact with the target tissues, 
these gets metabolically transformed in to more or less active 
metabolites. For the hormones like androgen and testosterone 
these transformation appear to be of particular importance, this 
also suggest that these steroids may be a perhormones. The 
brain, like the seminal vesicles, is able to convert testosterone to 
5a - dihydrotestosterone (DHT) and 3a -5a-androstanediol (Fig. 
I and II ) and also like the placenta, converts testosterone to 
estradiol (Fig. III). 
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FIG. - 2.2 
ANDROGEN HORMONES 
c 
o 
5a-dihydrotestosterone 3a.5a-androstaanediol 
17B-estradiol 
III 
progestesone 
VI 
5a-dyhydroprogesterone 
VII 
Conversion never occurs equally in all brain regions 
Regional distribution of 5a-reductase activity towards testosterone 
in rat brain is found in mid brain and brain stem with intermediate 
activity in hypothalamus and thalamus and lowest activity in 
cerebral cortex. The pituitary has higher 5a-reductase activity 
than any region of the brain and its activity is subjected to change 
as a result of gonadectomy, hormone replacement and postnatal 
age. 5a-Dihydrotestosterone has been implicated In hypothalamus 
and pituitary as a potent regulator to of gonadotropin secretion but 
is relatively inactive toward male rat sexual behavior (Feder : 
1971). 
It is interesting that progesterone (Fig. VI) inhibits 5a-
reductase activity toward (3H) testosterone and that (3H) 
progesterone is itself converted to (3H) 5a- dihydroprogesterone 
(Fig.VII) Progesterone competition for the 5a-reductase may 
explain some of the antiandrogenicity of this steroid, (Massa and 
Martin, 1972). 
The aromatization of testosterone to form estradiol (Fig. Ill) 
and of androstenediols (Fig.IV) to form esterone (Fig. V) has been 
described in brain tissue in vitro and in vivo (Naftolin et al. 1975 
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and Lieberburg. et al. 1975) A'omatization is higher m 
hypothalamus and limbs structures than in cerebral cortex or 
pituitary gland in noncastrated animals is higher in male than in 
female brains. Aromatization has been found in brains of reptiles 
and amphibia as well as in mammals, (Collard, et al. 1977 and 
Kelley et al. 1978). 
The capacity to aromatize testosterone and related 
androgens may therefore be a general property of vertebrate 
brains The functional role of aromatization has been studied most 
extensively in the rat. male sexua! behavior is facilitated by 
estradiol and testosterone (Davis and Barfield, 1979). 
Facilitation of male sexual behavior can be blocked by 
these steroids (Clemens, 1975 and Morali, et al. 1977). Similar 
situation exists in birds, amphibia and reptiles, testosterone and 
estradiol can stimulate heterotypical sexual behavior in male and 
females. Curiously, not all mammals are like the rat. For example. 
male sexual behavior of the guinea pig and rhesus monkey is 
restored by the nonaromatizable androgens androstenendione 
and dihyrotesosterone, (Alsum, and Goy, 1974). A number of 
other steroid transformations occur in brain tissue , but this 
metabolism dose not appear to be of importance for Interaction of 
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those hormones withthe putative receptor sites. It has been found 
that Both (3H) estradiol and (3H)-corticosterone are recovered 
from their binding sites in the brain (Mc Ewen, et al. 1972) 
2.4 PHYSIOLOGICAL FUNCTION AND PHARMACOLOGICAL 
EFFECTS OF STEROIDS : 
Corticosteroids have numerous wide spread effects on 
living system. They influence carbohydrate, protein and lipid 
metabolism, electrolyte and v^ater balance and the functions of 
cardiovascular system, kidney, skeletal muscles, nervous system 
and other organs and tissues 
Furthermore the cortico-steroids endow the organism with 
the capacity to resist many types of nexious stimuli and 
environmental changes In the absence of the adrenal cortex, 
survival is possible but only under the most rigidly prescribed 
conditions for example, food must be available regularly, sodium 
chloride ingested in the relatively large quantit ies, and 
environmental temperature maintained with in a suitably narrow 
range. A given dose of corticosteroids may be physiological or 
pharmacological, depending on the environment and the activities 
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of the organism. Under favorable conditions, a small dose of 
corticosteroids maintains the adrenalectomized animal in a state 
of well-being Under adverse conditions a relatively large dose is 
needed, if the animal is to survive This same large dose given 
repetitively under optimal conditions induces hyper-corticismthat 
is sign of corticosteroids excess. The function in the secretary 
activity of a normal subject are presumed to reflect the body's 
varying requirements for corticosteroids. 
The actions of corticosteroids are often complexly related to 
the functions of other hormones For example in the absence of 
lipolitic hormones, Cortisol, even in large concentrations, has 
virtually no effect on the rate of lipolysis in adipose tissue in vitro. 
Likev^ise, a sympathomimetic amine has only a slight effect on the 
rate of lipolysis if there is a deficiency of glucocorticoids. However, 
if a necessary minimal amount of Cortisol is added, the lipolitic 
effect of the sympathomimetic amine become evident The 
necessary but not sufficient role of corticosteroids acting in 
concert with other regulatory forces has been termed "permissive ' 
Estimates of the potencies of naturally occurring and 
synthetic corticosteroids in the categories of Na* retention 
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(Reduction of Na+ excretion by the kidney of the adrenalectomized 
animal), hepatic deposition of glycogen in fasted adrenalectomized 
animals, and inflammatory effect (inhibition of the action of an 
agent that induces inflammation) are presented in Table 2 1 It 
should noted that such values are not fixed ratios but very 
considerably with the conditions of the bioassays used. Potencies 
of steroids as judged by their ability to sustain life in the 
adrenalectomized animal closely parallel those determined for 
Na* retention. Potencies based on deposition of linear glycogen, 
antiinflammatory effect, work capacity of skeletal muscles, and 
involution of lymphoid tissues closely parallel one another. 
Dissociations exist between pp based on Na* retention and on 
hepatic glycogen deposition traditionally, the corticosteroids have 
thus been classified into mineralocorticoids and glycocorticoids, 
according to the potencies in the two categories (Robert, Hynes 
1980). 
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TABLE - 2.1 
RELATIVE POTENCIES OF CORTICOSTEROIDS 
Na+ Hepatic Anti-inflammatory 
Retention Glycogen 
Deposition 
effect 
Natural steroids 
Cortisol r 1 
Cortisone 0.8* 0.8 
Corticosterone 15 0.35 
ll-Desoxy 
Corticosterone 100 0.00 
Aldosterone 3000 0.3 
1 
0.8 
0.3 
0.00 
9 
Synthetic Steroids 
Prednisolone 
Triamcinolone 
r 
0.00 
4 
5 
4 
5 
•Promotes excretion of Na* under certain circumstances. 
Glucocorticoids are widely used therapeutically for their 
Immunosuppressive and antiinflammatory effect (Kathurina Binz 
e ta l . 1994). 
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Adrenal steroids have been found to facilitate a form 
behavioral adaptation in the absence of external stressors adrenal 
steroids are also secreted in varying amounts according to the 
time of day. In nocturnaily active animals as the rat and in animals 
such human being which are active during the day, the peak of this 
basal secretion always occurs near the end of the sleep period. 
Thus it is conceivable that adrenal steroid secretion may modulate 
behavior as a function of the time of day. Indeed it has been 
reported that adrenal steroids modify the detection and recognition 
thresholds for a variety of sensory stimuli and influence the 
occurrence of the (so-called) rapid eye movement or paradoxical 
phase of sleep (Bhous 1973) and Mc Ewen et al. (1975) 
Desoxy cor t icosterone, the prototype of the 
mineralocorticoids, is highly potent in regard to Na+ retention but 
without effect on hepatic glycogen deposition Cortisol the prototype 
of the glucocorticoids is highly potent in regard to linear glycogen 
deposition but weak in regard to Na* retention. The naturally 
occurring corticosteroids Cortisol and cortisone, as well as synthetic 
corticosteroids such as prednisolone and triamcinolone, are 
classified as glucocorticoids. However, corticosterone is a steroid 
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that has modest but significant activities in both categories In 
contrast, aldosterone is exceedingly potent with respect to Na* 
retention but has only modest potency for linear glycogen 
deposition. At rates secreted by the adrenal cortex or in doses that 
exert maximal effect on electrolyte balance, aldosterone has no 
significant effect on carbohydrate metabolism, It is thus classified 
as a mineralocorticoids (Robert Hynes ^1980). 
2.4.1 Mechanism of Action : 
The hormones like Adrenal steroids mineralocortlcos- teroids 
etc act by controlling the rate of synthesis of proteins. (Bruce and 
A^ c Ewen, 1981; James and Nathanson, 1981) However, their 
nearly instantaneous inhibition of ACTH release is an exception. 
These steroids react with receptor proteins in the cytoplasm of 
sensitive cells in many tissues to form a steroid receptor complex. 
The complex undergoes a modification, as noted by an increase 
in the sedimentation constant and moves in to the nucleus, where 
It binds to chromatin and regulates transcription of specific genes. 
^^  most known examples, transcription Is enhanced as manifest by 
Increased amount of specific mRNA. Inspite of these facts 
glucocorticoids exceptionally decrease rate of transcription. 
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2.5 STRUCTURE-ACTIVITY RELATIONSHIP OF STEROIDS : 
Structural modification in the Cortisol nnolecule have led to 
Increase in the ratio of antiinflammatory to Na* retaining potency. 
Electrolytic effects exerted by most of these steroids are of no 
. nervous consequences. However, effects on inflammation and on 
carbohydrate and protein metabolism have always paralleled one 
another, and it seems very likely that these effects are mediated 
by the same type of receptor. 
Change in the moleculer structure may bring about changes 
in biological potency as a result of alteration in absorption protein 
binding rate of metabolic transformation, rate of excretion ability 
to traverse membranes, and intrinsic effectiveness of the molecule 
at its site of action. In the following paragraphs, modification of the 
pregnane nucleus that have been of value in therapeutic agents 
are described in following figures. Following list show the effects 
of the modifications discussed relative to Cortisol. 
27 
TABLE - 2.2 
RELATIVE POTENCIES AND EQUIVALENT DOSES OF 
CORTICOSTEROIDS 
Compound Relative Relative Duration Approx 
Antiinfia 
mmatory 
Retaining 
Na-
of action Equiv 
potencies potency Dose* 
(mg) 
Cort isol (Hydrocort isone) 1 1 S 20 
Tetra Hydrocort isol 0 0 - -
Prednisone 
(^ ' -Cort isone) 4 0 8 1 5 
Prednisolone 
C^  • -Cort isol) 4 0 8 1 5 
'^6a-Methylprednisolone 5 0 5 1 4 
Flurocort isone (9a-f lurocort isol) 10 125 S -
11-Desoxycort isol 0 0 - -
Cort isone (11-Dehy-drocort isol) 0.8 0.8 s 25 
Cort icosterone 0 35 15 s -
Tr iamcinolone {9a- f luro-16a-
methylPrednisolone) 5 0 1 4 
Betamethasone (9a-Fluro-16P-
methyl prednisolone) 25 0 L 2 
Dexamethasone (9a-Fluro-
methyl prednisolone) 25 0 L 0 75 
Paramethasone (6a-Fluro-16a-
methylprednisolone) 10 0 L 0 75 
*S = Short or 8to 12 hour biological half life; 
I = Intermediate or 12 to 36 hour biological half life; 
L = Long or 36 to 72 hour biological half life 
2X 
FIG. - 2.3 
CHaPH 
II 
Structure-stereochemistry and nomenclature of adrenocosteroids, 
as typsified by Cortisol (hydrocortisone) 
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These dose relationship apply only to oral or intravenous 
administration, relative potencies maydiffer greatly when injected 
intramusculary or in to joint spaces 
Ring A : 
The 4.5 double bond and the 3-ketone are both necessary 
for typical adrenocorticosteroid activity. Introduction of a 1.2 
double bond as in prednisone or prednisolone, enhances the ratio 
of carbohydrate regulating potency by selectively increasing the 
former In addition, prednisolone is metabolized more slowly than 
Cortisol 
Ring B : 
6a-substitution has unpredictable effects. In the particular 
Instance of Cortisol, 6a-methylation increases anti-Inflammatory, 
nitrogen wasting and Na* retaining effects in man. In contrast 6a-
methylprednisolone has slightly greater antiinflammatory potency 
less electrolyte retaining potency than prednisolone. Fluorination 
in the 9a-positing enhances all biological activities of the 
corticosteroids, apparently by its election withdrawing effect on 
the 1ip-hydroxy group. 
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Ring C : 
The presence of an oxygen function at C-11 is indispensable 
for significant antiinflammatory and carbohydrate regulating 
potency (Cortisol versus 11-desoxycortisol) but it is not necessary 
for high Na* retaining potency as demonstrated by 
desocycorticosterone. 
Ring D : 
16-Methylation or hydroxylation eliminates the Na* retaining 
effect but only slightly modified potency with respect to effects on 
metabolism and inflammation. 
Presently used all the anti-inflammatory steroids are 17a-
hydroxy compounds. Although some carbohydrate regulating and 
antiinflammatory effects may occur in 7-desoxy compounds 
(Cortisol versus corticosterone), the fullest expression of these 
activities the presence of the 17a-hydroxy substituent. 
All natural corticosteroids and most of the active synthetic 
analogues have a 21-hydroxy group . While some glycogenic and 
antiinflammatory activities may occur in its absence its presence 
is required for significant Na* retaining activity. 
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The four rings A. B. C and D are not in a flat plane as 
conventionally represented m I but have the approximate 
configuration shown in II (The planarity of the valence angles 
about the double bond betv^een C-4 and C-5 prevents the chair 
form of ring A. as from being an energetically probable 
conformational state As a result ring A is in a half-chair 
conformation not easily represented in two dimar ions). Orientation 
of the group attached to the steroid ring system is important for 
biological activity. The methyl groups at C-18 and C-19 the 
hydroxyl group at C-11 and the two carbon Ketol side chain at C-
17 project above the plane of the steroid and are designated Q> 
Their connection to the ring system is shown by full line bonds. 
The hydroxy at C-17 projects below the plane and Is designated 
a and the connection to the ring is shown by a dotted bond 
2.6 EFFECTS OF ADRENOCORTICAL STEROID ON CNS : 
The corticosteroids affect the central nervous system (CNS) 
in a number of indirect ways. These steroids particularly maintain 
normal concentration of glucose in plasma, they also ensure the 
adequate circulation and the normal balance of electrolytes in the 
body. There Is also an increasing recognition of direct effects of 
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corticosteroids on the CNS as understanding of the distribution 
and function of steroid in the brain (Mc Ewen et al. 1986 ; Funder 
and Sheepard, 1987). An influence of the corticosteroids can be 
observed on mood, behavior the electroencephalogram (EEG) 
and brain excitability. 
Patients with Addison's disease exhibit apathy depression 
and irritability, some are frankly psychotic Desoxycorticosterone 
is ineffective but Cortisol is very effective in correcting these 
abnormalities of psyche and behavior. An array of reactions 
varying in degree and kind is seen in patients to whom 
glucocorticoids administered for therapeutic purposes. Most 
patient respond elevation in mood, which may be explained in part 
by the relief of the symptoms of the disease being treated. In 
some, more definite mood changes occur, characterized by 
euphoria, insomnia restlessness, and increase motor activity. A 
smaller but significant percentage of patients treated with high 
doses of Cortisol become anxious or depressed and a still smaller 
percentage exhibit psychotic reactions. A high incident of neuroses 
and psychoses has been noted among patients with Cushing's 
syndrome. The abnormalities of behavior usually disappear when 
the corticosteroids are withdrawn or Cushing's syndrome is 
effectively treated (Lewis et al. 1983). 
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There is an increase in the excitability of neural tissue 
hypocorticism and a decreased excitability in animals giving large 
doses of desoxycorticosterone, these alterations appear to be 
related to change in the concentration of electrolytes in the brain. 
In contrast administration of Cortisol increase brain excitability 
without influencing the concentration of Na* and K* in the brain. 
Thus it has been concluded that the inf luence of 
desoxycorticosterone on excitability is mediated through its 
influence on Na* transport whereas Cortisol acts by cytoplasmic 
receptors (Mc Ewen. 1979 ; Carpenter and Cruen, 1982). Steroid 
hormones are classically implicated in the maintenance of 
homeostasis of an organisms internal milieu in the response to 
emergency environmental demands and in the process of sexual 
reproduction. Steroid hormones have special role in the timing 
and sequential integration of the development of neural processes 
(Charles 1986). In addition to less serious complaints such as 
dermatitis and tennis elbow>relevated plasma Cortisol levels are 
also associated with effective endocrine disorders, such as those 
associated with endogenous depression (Prange et al. 1977). 
Glucocorticoids may have direct, non-receptor mediated effects 
34 
on neural membranes and that chronic dosmg with exogenous 
glucocorticoids greatly enhances brain excitability (Woodbury, 
1958; Hall, 1982) Thus itmay be that these alterationsm behavioral 
excitability, typically attributed to enhanced neuronal excitability 
(Ecobichon and Joy. 1982) Sex hormones may alter neural 
excitability in a biphasic manner in desecrated brain regions such 
as the hippocampus (Teyler, et al., 1980), 
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A) MATERIALS : 
3.01 ANIMALS : 
Male albino rats of Charles Foster Strain (250 ± 50 
grams).obtained from animal house, J.N. Medical college, A.M.U. 
Aligarh. 
3.02 PREPARATION OF STEROIDS FOR BIOCHEMICAL 
STUDIES 
3.02.1 SR-Acetoxy'Cholest-S-ene 
A mixture of cholesterol (SO.OOgm). pyridine (75 ml) and 
acetic anhydride (50 ml) was heated on a steam bath for 2 hours. 
The resulting brown solution was poured onto crushed ice-water 
mixture with constant stirring. A light brown solid thus obtained 
was filtered under suction, washed with water until free from 
pyridine and air dried The crude product on recrystallization from 
acetone gave pure 3B- acetoxy-cholest-5-ene (45 gm) with mp 
114°C (reported, mp 116°C) (Backer and Squire, 1987). 
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3.02.2 3B- acetoxy-6-nitrO'Cholest'5-ene 
3B - actoxycholest-5-ene (10 gm) was covered with nitric 
acid (d=1 . 52:250 ml) and sodium nitrite (10 gm) was gradually 
added over a period of one hour, with continuous stirring slight 
, cooling was also required during the reaction. Stirring was 
continued for additional 2 hours, when yellow, spongy mass 
separated on the surface of mixture. This was diluted with ice cold 
water (250 ml). A green coloured solution was obtained. The 
whole mass was extracted with ether and washed successively 
with water, sodium bicarbonate solution (5%) and water. The 
ethereal layer was dried over anhydrous sodium sulphate. Removal 
solvent provided an oil which was crystallized from methanol to 
get 3J5-acetoxy-6-nitrocholest-5-ene (6.8 gm). mp 103.9°C 
(reported, mp 104°C). (Anagno Stopoules and Fieser, 1954). 
3.02.3 3fi->)cefoxy-5a-c/)o/esran-6-one ; 
3B-acetoxy-6-nitrocholest-5-ene (6 gm) was dissolved in 
glacialacetic acid (250 ml) by warming the mixture. Zinc dust (12 
gm) was added in small portions with continuous shaking and the 
suspension was heated under reflux for four hours. Water (12 ml) 
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was added occasionally during the course of reaction. The l^ iot 
solution was filtered, cooled to room temperature and diluted with 
a large excess of ice cold water. The organic matter was extracted 
with ether and ethereal solution, was worked up and dried In usual 
nnanner removal of solvent furnished the ketone as on oil which 
was recrystallized from methanol (4.2 gm), mp.128-129°C 
(reported, mp.127-129°C). (Dodson, and Reigel, 1948). 
3.03 STRUCTURE OF THE STEROIDS USED IN THIS STUDY 
AcO 
3Bi-acetoxy-cholest-5-ene 
Fieser. L.F et al. (1959) 
(I) 
ACQ 
N0=, 
3(j-acetoxy-6-nitro-cholest-5-ent 
Anagno stopoules (1954). 
(H) 
3a-acetoxy-5a-cholestan-6-one 
Dodson etal. (1948) 
(III) 
3.04 REAGENTS : 
All the chemical used in this study were of analytical reagent 
grade. The chemicalswere obtained from Sigma Chemicals Co. 
(St. Louis, Mo, U.S.A). AldrichChemical Companyu.S.A, B D H. 
Chemical Ltd., Poole England, E. Merck, Germany and Sisco 
Research Laboratories, Bombay, India. 
1. 3B-acetoxy-cholest-6-ene 
2. 3(i-acetoxy-6-nitro-cholest-5-ene 
3. 3(i-acetoxy-5-a-cholestan-6-one 
4. Pyridine 
5. Acetic anhydride 
6. Acetone 
7. Nitric acid 
8. Sodium nitrate 
9. Sodium bicarbonate 
10. Ether 
11. Sodium sulphate (anhydrous) 
12. Methanol 
13. Glacial acetic acid 
14. Zinc dust 
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15. Sodium chloride 
16. Chloroform 
17. Brain lipids 
18. Cone. HjSO^ 
19. Potassium dihydrogen orthophosphate 
20. Vanillin 
21. Double distilled water 
22. Ammonium molybdate 
23. Perchloric acid 
24. Sodium bisulphite 
25. Sodium sulphate 
26. 1-amino-2-napthol-4-sulphonic acid (ANSA) 
27. Cholesterol 
28. Ferric chloride 
29. Sialic acid 
30. Recorcinol 
31. Butyl acetate 
32. n-butanol 
33. N-acetylneuramlnic acid (NANA) 
34. Cone. Hydro Chloric Acid 
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35. Copper sulphate 
36. Triolein 
37. Ethyl alcohol 
38. Hydroxyl Amine Hydrochloride 
39. Sodium Hydroxide 
40. Potassium chloride 
41. Trichloro acetic acid (TCA) 
42. Thiobarbituric acid (TBA) 
43. Pea nut oil 
44. pH tablets 
3.05 INSTRUMENTS : 
1. DU-6 Beckman spectrophotometer 
2. Oven (NSW, India) 
3. pH-meter (elico) with double combine electrode 
4. Metabolic shaker (NSW, India) 
5. Single Electric Balance (varbal) 
6. Boiling water bath (Technico India) 
7. Digestor (Designed in our center) 
8. Vacuum drier 
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9. Homogenizer (Yorco Scientific Industries) 
10. Stirrer (Yorco Sales Pvt./Ltd). 
11. Double distillation plant for water 
12. Single distillation plant with heating mantle for 
purification. 
3.06 MISCELLANEOUS : 
1. Ice Bath 
2. Pellet diet (Hindustan Lever Ltd., India) 
3. Plastic eages 
4. 1 nnl tuberculin glass syringe 
5. Needle (26 number) 
6. Screw capped culture tubes 
7. Sintered glass funnel 
8. Homogenizing tube 
9. Pasteur pipette 
10. Glass beeds 
11. Vials (10 ml). 
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B) METHODS 
3.07 PROCEDURE AND MAINTENANCE OF ANIMALS : 
Healthy male albino rats of Charles Foster Strain, obtained 
fromtheanimalhouse, J.N. Medical college, A.M.U.,Aligarh were 
used in the present study. They were divided Into four groups. 
Group 1: 6 months, wt. = 250 ± 60 grams 
Group 2: 6 months, wt. = 250 ± 50 grams 
Group 3: 6 months, wt. = 250 ± 50 grams 
Group 4: 6 months, wt. = 250 ± 50 grams 
Female rats were excluded from the study because of their 
cyclic hormonal variations. 
The rats kept on pellet diet (Hindustan Lever Ltd., India) 
measuring upto the U.S. National Research Council Publication 
No.990, titled "NationalRequirements ofLaboratoryAnimals" They 
were housed singly in plastic cages placed in a room maintained 
at 23 ± 1°C. The animal room and cages were cleaned daily to 
keep them dust free. Light-dark (photo period) was controlled 
between 8:00 AM to 8:00 P.M. The hygienic and sanitary conditions 
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were adequately maintained. The rats showing sings of any 
disease were removed immediately after identification. 
3.08 SOLUTION PREPARATION AND DOSE ADMINISTRATION 
0.3 mg/kg body wt. steroid were given to the rats. The 
solution for Injection to the rats was prepared in pea-nut oil and 
was made keeping in mind that the amount of the oil to be injection 
to the animal should not exceed approximately 0.1 ml, to avoid the 
accumulation of fat (lipids) in albino rats. The solution was 
prepared by adding 6.75 mg reference steroid in 9 ml of peanut oil. 
The steroids were injection intraperltonially with the help of 1 ml 
tuberculin glass syringe and 26 number needle. A new needle for 
each animal was used daily . The syringes were sterilized each 
day by boiling in water and rinsing with methanol. 
Group 1 : (Control) of 6 male albino rats were injected normal 
saline equal to the volume of steroidal solution injected 
in experimental rats for 15 days. 
Group 2 : (Experimental) was Injected 3-6-acetoxy-choiest-5-
ene, 0.3 mg/kg body wt. for 15 days. 
Group 3 : (Experimental), was injected 3-fi-acetoxy-6-nitro-
cholest-5-ene, 0.3 mg/kg body wt. for 15 days. 
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A l b i n o R a t 
% 
DISSECTED BRAIN OF ALBINO RAT 
Fig. 3.01 
Fig-301 
Photograph showing the rJorsal view of Rat Brain 
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h Cerebral 
hemisphere 
r Brain stem 
r Spinal cord 
Dissection of deff erent parts of the rat 
CNS IMcEwen and Praff 1970.). 
Group 4 : (Experimental) was injected 3-B-acetoxy-5-a-
cholestan-6-one, 0.3 mg/kg body wt. for 15 days. 
3.09 DISSECTION OF DIFFERENT PARTS OF THE RAT'S 
BRAIN : 
For all biochemical investigations, fresh unfixed brain was 
used. The brain and spinal cord were removed rapidly from 
Individual rats and dissected out on an ice plate. The blood clots 
adhering to brain were removed by washing with the cold normal 
saline. Thereafter, the cerebrum,cerebellum brain stem and spinal 
cord were rapidly dissected out and weighed to the nearest 
milligram on an electrical balance,some of the brain components 
like hippocampus, hypothalamus and cerebellum were pooled 
and used for biochemical analysis. 
3.10 PROCEDURE FOR KILLING AND DISSECTING THE 
ANIMAL : 
3.10.1 Cervical Dislocation : 
For biochemical and most of the histochemical studies 
where perfusion of the rat brain was not required the animal were 
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killed by cervical dislocation one of the most acceptable methods 
euthanasia. The control as well as experimental rats were grasped 
at their neck the base of skull, the thumb forefinger of one hand, 
and hind limbs and tail the other. A swift but controlled motion 
separated the cervical vertebrae from the base of skull. This 
resulted in instantaneous loss of consciousness and loss of all 
vital sings within a few minutes. 
3.10.2 Exposure of the Brain and its Removal: 
The head of rats (Killed by cervical dislocation and skinned). 
The skeletal converings over the skull were removed with the use 
of a small pair of bone forceps, scalpel, scissors and nail clippers. 
Great care was taken to avoid any laceration of brain tissue. After 
exposing the brain surface from the top and sides, it was gently 
detached from the base of skull and removed. 
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C) BIOCHEMICAL 
STUDIES 
"-^  '" 
C) BIOCHEMICAL STUDIES : 
3.11 EXTRACTION AND PURIFICATION OF BRAIN LIPIDS : 
Lipids from brain regions were extracted and purified 
immediately after dissection of the animal by the method of Folch 
et al. (1957). This method was partially modified in our laboratory 
(Islam etal. 1980)for isolation of lipids from discrete areas of the 
brain. Different parts of the brain were weighed and homogenized 
(10% w/v) in a glass homogenizer to a final volume of 6 ml 
chloroform;methanol mixture (2:1, v/v). Each homogenate was 
shaken periodically for an hour and filtered through sintered glass 
funnel (G-4) under vacuum (Fig. 3.02). The residue of each test 
tube was again homogenized with 2 ml chloroform-methanol 
mixture and filtered. The resultant residue was washed several 
times with the solvent mixture to ensure complete extraction of 
lipids. The final volume of each extract was made up to 10 ml with 
chloroform-methanol mixture in a graduated test tube. There after, 
2.5 ml of 0.9% NaCI was added to the extract In each test tube. 
This was shaken vigorously on test tube mixer for complete mixing 
and placed at -20°C in a deep freeze overnight for complete 
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separation of the two layers. The junction of the layers of each test 
tube was marked. The upper aqueous layer was taken out with a 
specially designed syringe (Fig 3) without disturbing the interfacial 
fluff. This upper layerwas used forthe estimation of gangliosides. 
The lower lipid layer was made homogeneous by adding 
required amount of methanol make the final volume to 10 ml and 
transferred to round bottom flask and dried under vacuum at 40°C. 
In order to remove proteins, the residue was dissolved in 
chloroform-methanol-water mixture (64:32 ; 4 v/v) and evaporated 
to dryness. The contents were suspended in chloroform-methanol 
(2:1 v/v) mixture and evaporated to dryness. This process was 
repeated again until moisture was completely removed from 
lipids. The lipids were then suspended in chloroform, Filtered free 
of any protein, and the filtrate was dried under vacuum at 40°C. 
The dried lipids were solubilized to a known volume with chloroform 
and stored at -20 C till further use. This extract was used for the 
estimation of total lipids, triglycerides and cholesterol. 
3.12 ESTIMATION OF TOTAL LIPIDS : 
Total lipids were estimated according to the method of 
Woodman and Price (1972). 
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3.12.1 Principle: 
Colour was developed with the help of colouring reagent 
(phosho-vanillin) In the presence of sulphric acid (HjSO^) and 
absorbance was read at 540 nm. The details of the reaction are 
given below. Sulphuric acid acts upon the double bonds on lipids 
to produce carbonium ion which simultaneously reacts with 
phosphate ester of vanillin to form a coloured complex with an 
absorption maximum at 540 nm. 
3.12.2 Reagent solutions : 
(i) Standard solution : 
A standard solution of 0.5 mg brain lipid/ml in chloroform-
methanol mixture (2:1 v/v) was prepared by diluting 1.0 ml of 
refrigerated stock solution (50 mg brain lipid/10 ml) in chloroform-
methanol mixture, in a 10 ml volumetric flask and the volume was 
made upto the mark with chloroform-methanol mixture. 
H H H H 
I I I I 
I I I I 
HjSO, + R - C = C C — C — + R+ 1 -H 
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(ii) Concentrated sulphuric acid (A.R.) 
(iii) Colouring reagent: 
6.0 grams of potassium dihydrogen orthophosphate (KH^PO )^ 
and 0.39 grams of vanillin were dissolved by heating in double 
distilled v^ ater and made up the volume to 100 ml in a volumetric 
flask. 
(iv) Brain lipid : 
Lipids were isolated from the rat brain by the technique 
described in the extraction and purification of lipids. 
3.12.3 Procedure : 
0.1 ml of brain extract in duplicate was taken in 18 x 150 mm 
corning test tubes. Cone, sulphuric acid (2.5 ml) was added to test 
tube and heated on boiling water bath for 20 minutes. After cooling 
5.0 ml of colouring reagent was added and absorption was read 
at 540 nm after exactly 10 minutes in.DU-6 Beckman 
spectrophotometer against a reagent blank. A calibration curve of 
absorbance in concentration (100-600 ug) of standard brain lipids 
was prepared by adopting the same procedure as described 
above. The values of the standard curve were plotted by least 
square method. The absorbance of total lipids in brain samples 
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were compared with curve and finally calculated by the following 
formula : 
3.12.4 Calculation : 
C X V 
Totallipids (mg/g of fresh brain weight) = 
V. X W. 
Where, 
C = Concentration of lipids in ug in 0.1 ml extract 
V = Total volume of the total lipids extract 
V, = Volume taken for the estimation 
W, = Fresh weight of the tissue in mg. 
3.13 ESTIMATION OF PHOPHOLIPIDS : 
Total Phopholipids were calculated by estimating 
phosphorous following the method of Fiske and Subba Rao (1925) 
as modified by Marinetti (1962). 
3.13.1 Principle: 
Organic phosphorous of phospholipds was converted to 
inorganic phosphorous by digesting the lipids with perchloric acid 
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when acid hydrolysate is treated with molybdate, it forms 
phosphomolybdic acid with inorganic phosphorous. Thus 
phosphomolybdic acid is reduced by the addition of 1.2,4-
aminonapthal sulphonic acid (ANSA) reagent to produce a blue 
coloured complex. The intensity of the blue colour, which is 
proportional to the amount of Inorganic phosphorous present, was 
read at 700 nm. Inorganic phosphate contentswas multiplied by 
25 to convert into a lecithin equivalent to organic phospholipid. 
3.13.2 Reagents : 
i) Standard solution : 
A standard solution of 0.1 mg inorganic phosphate/ml was 
prepared by diluting 5.0 ml of refrigerated stock solution (0.439 g 
KH2PO/5OO ml DDW) in a 100 ml volumetric flask with double 
distilled water. 
li) 2.5% Ammonium molybdate solution : 
2.5 g of Ammonium molybdate was dissolved in 100 ml 
double distilled water. 
iii) Perchloric Acid (70%). 
iv) Reducing Reagent: 
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3.0 gram of analytical grade sodium bisulphite 0.6 g sodium 
sulphate and 0.05 g recrystallized 1-amino-2-napthol-4-sulphonic 
acid (ANSA) were dissolved in 25 ml double distilled water. A 
slight yellow solution thus obtained was stored in an amber colour 
bottle. The yellow colour is stable for a week at room temperature. 
3.13.37 Procedure : 
The tube containing 0.2 ml of brain lipid extracts in duplicate 
were dried and added with 1.0 ml of reagent grade perchloric acid. 
Contents were digested over sand bath maintained at 180°Cfor 
about 30 minutes till the digestion mixture was colour less. Glass 
beads were introduced to each tube to avoid bumping. After 
digestion, the samples were cooled to room temperature and 1.5 
ml ammonium molybdate, 0.2 ml reducing reagent and 7.0 ml 
double distilled water were added to each sample. Thereafter, the 
whole mixture was mixed thoroughly in each test tube.The tube 
were heated in a boiling water bath for 7 minutes, cooled to room 
temperature and read at 700 nm at against a reagent blank 
(prepared by treating 1.0 ml perchloric acid in the same way as 
samples) simultaneously, different concentrations of standard 
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KHjPO^ solution were also estimated as above. The values of 
absorbance vs concentrations were plotted for calibration curve 
by least square method. 
3.13.4 Calculation : 
Phosphorous content in the sample was calculated using 
the standard curve and the amount of phospholipid in the sample 
was calculated by multiplying the phosphorous content with 25 
(factor). The results were expressed in mg phospholipids/g tissue 
weight. 
3.14 ESTIMATION OF CHOLESTEROL : 
Total cholesterol was estimated according to the method of 
Zlatisetal. (1954). 
3.14.1 Principle : 
Cholesterol dissolved with acetic acid and in the presence 
of FeClg-HjSG^ reagent gets dehydrogenated to 3,5 cholestadiene 
or2,4-cholestadiene which simultaneously poiymerizesand reacts 
with FeClg to form a violet coloured complex which Is measured 
clorimetrically at 570 nm. 
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3.14.2 Reagents : 
i) Standard solution : 
A standard solution of 1.0 mg/ml cholesterol in acetic acid 
was prepared by diluting 1.0 ml of stock solution (100 mg 
cholesterol in 10 ml acetic acid) in 10 ml volumetric flask and the 
volume was made to 10 ml with acetic acid. 
ii) Giaciai acetic acid. 
iii) Concentrated Sulphuric Acid. 
(iv) StoclcFerric Chloridereagent. 
5.0 g of anyhydrous ferric chloride was dissolved in 50 ml of 
glacial acetic acid. 
v) WorkingFerric Chloridereagent. 
1.0 ml of stock ferric chloride was diluted to 100 ml with 
concentrated sulphuric acid. 
3.14.3 Procedure : 
Brain extract (0.05 ml) was taken in duplicate in dry 15x 150 
mm test tubes, dried and dissolved in 3 ml glacial acetic acid. 
Working ferric chloride solution (2 ml) was added and the contents 
were mixed thoroughly. The tubes were kept in dark for 30 minutes 
and the optical density was then measured at 570 nm. Reagent 
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blank and standard cholesteral solutions were also run 
simultaneously. 
3.14.4 Calculation : 
Standard curve of cholesterol was used to calculate the 
amount of cholesterol in the samples and results were expressed 
as mg/chloesterol/g tissue weight. 
3.15 ESTIMATION OF GANGLIOSIDES : 
Gangliosldes were estimated according to Pollet et al. 
(1978) after modification in the methods of Svennerholm (1957)^ 
Miettinene and Takki-Luukkainen (1959). 
3.16.1 Principle : 
Bound sialic acids in the gangliosldes were isolated carefully 
without their degradations. When samples are heated at 100°C 
in a boiling water-bath for 30 minutes in resorcinol reagent, the 
pentose sugar moities break up and make a coloured complex 
with resorcinol reagent. This coloured complex is extracted in 
organic solvent (butylacetate and n-butanol; 85:15, v/v). Organic 
phase was taken and abosrbance was measured at 580 nm. 
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3.15.2 Reagents : 
i) Standard solution : 
A stock standard was prepared by dissolving 100 mg N-
acetylneuraminic acid in double distilled water and making the 
final volume to 100 ml. This gives 1.0 mg N-acetlneuraminic acid/ 
ml. Working standard was prepared by taking 1.0 ml of stock 
standard and diluting it to 10 ml in a volumetric flask with c. jje 
distilled water. This is 100 ug/ml of N-acetylneuraminic a ^ 1 . 
il) Resoscinol Reagent: 
This reagent was prepared by mixing 10 ml of 3.0 /o 
resorcinol solution in double distilled water, 80 ml of concentraied 
HCI, 0.25 ml of 0.1 N copper sulphate and double distilled water 
upto 100 ml mark in a volumetric flask. 
iii) Butyl acetate. 
Iv) n-Butanol. 
3.15.3 Procedure : 
Recorcinol reagent (2 ml) was added to 2.0 ml of the upper 
layer (aqueous) of lipid extract, and heated in a boiling water bath 
for 30 minutes. After cooling to room temperature, 5.0 ml of 
mixture of butyl acetate and n-butanol (85 : 15, v/v) was added to 
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each tube. The tubes were shaken thoroughly and kept for 15 
minutes to separate the organic phase. About 3-4 ml of organic 
phase was taken and absorbance was measured 580 nm against 
a reagent blank. A standard curve with absorbance of different 
concentrations of n-acetylneuraminic acid (5-30 ug) having 2 ml 
final volume was prepared by treating in the same way as samples. 
The absorbance of test samples were compared with those of 
standard curve and gangliosides were quantitated as below. 
C X V 
V, X W, 
3.15.4 Calculation : 
Ganglioside (mg/g fresh brain weight) = 
Where, 
C = Concentration in gm in 2.0 ml extract 
V = Total volume of the upper layer 
V, = Volume taken for estimation 
W, = Fresh weight of brain tissue in mg. 
3.16 ESTIMATION OF ESTERFIED FATTY ACIDS : 
Esterified fatty acids were estimated according to the method 
of Sterm and Shapiro (1993) as follows 
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3.16.1 Reagents : 
i) Standard Solution : 
A standard solution of 4.0 g of trioleinin alcohol-ether (3.1) 
was prepared by diluting 1.0 ml of 1.0 meq stock solution (59 mg 
trlolein/5 ml alcohol etherX3:1) to a final volume of 10 ml with 
alcohol-ether mixture. 
ii) 2.0 M Hydroxylamine Hydrochloride (Solution I) : 
13.9 gms of hydroxylamine hydrochloride was dissolved in 
100 ml double distilled water. 
iii) 3.5 N Sodium Hydroxide (Solution ii) : 
14.Og of Sodium hydroxide (14.0 g) was dissolved in 100 ml 
double distilled water. 
iv) Hydroxylamine - Sodium Hydroxide : 
This was made before use by mixing equal volumes of 
solutions I and II. 
v) 0.37 M Ferric Chloride In 0.1 N HCI : 
The solution was prepared by dissolving 6.0 g FeClj in 100 
ml 0.1 N HCI. 
vi) 4.0 N Hydrochloric Acid Solution : 
This was prepared by adding 1 part of analytical grade 
concentrated HCI to 2 parts of double distilled water. 
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vii) Alcohol Ether (3:1) Mixture : 
3 parts of 95% ethanol were added to 1 part of ethyl ether 
(peroxide free). 
vlll) Peroxide Free Ether: 
This solution was obtained by adding a little hydroxylamine 
hydrochloride to the stock ether bottle perior to distillation of 
ether. The ether used in the procedure was freshly distilled. 
3.16.2 Procedure : 
Brain extracts of 0.6 ml were taken in 16 x 150 mm screw 
capped culture tubes to dryness at room temperature. A 3.0 ml 
aliquet of the alcohol ether (3:1) was pipetted to each tube and 1.0 
ml of hydroxylamine hydroxide solution was added, the contents 
were mixed and allowed to stand for 20 minunutes at room 
temperature. 4 N HCI (0.6 ml) and 0.5 ml of ferric chloride solution 
were added and mixed after each addition. A dark brown colour 
developed and was measured at 520 nm against a reagent blank. 
A calibration curve was drawn by using 0.1 to 0.6 ml of the 
standard solution (4.0 g/ml) with the volume made up to 3.0 ml 
with alcohol-ether mixture. 
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3.16.3 Calculation : 
O.D. of unknown x nneq of standard 
Meq esterified fatly acid in 3.0 ml aliquot = 
O.D. of standard 
3.17 DETERMINATION OF THE RATE OF LIPID 
PEROXIDATION : 
The procedure of Utiey et al. (1967) was used for finding out 
the rate of lipid peroxidation. 
15.7.1 Reagents : 
I) 0.15 M Potassium Chloride : 
This solution was prepared by dissolving 2.237 g KCI in 200 
ml double distilled water. 
li) 10% Trichloroacetic add (TCA) : 
10% TCA was prepared by dissolving 10 gm TCA in 100 mg 
distilled water. 
Ill) 0.67% Thiobarblturic Add (TBA) : 
Thiobarbituric acid 0.67 g was dissolved in 25-50 ml double 
distilled water by adding two pellets of NaOH. The pH of the 
solution was adjusted to 7.2 with the help of 1 N HCI and volume 
was made upto 100 ml with double distilled water. 
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3.17.2 Procedure : 
Different parts of the brain were homogenized (10% v/v) in 
chilled 0.15 M HCI. One ml of each homogenate was taken in a 
25 ml conical flask and incubated at 37 ± 1 °C In a metabolic shaker 
(120strokes/min, amplitudes 1 cm) for three hours, thereafter 1.0 
ml of the same homogenate was pipetted in centrifuge tube and 
protein was precipited by adding 1.0 ml of 10% TCA. After 
incubation 1.0 ml of 10% TCA was added and the reaction mixture 
was centrifuged at 3000 rpm for 10 minuutes. One ml of the clear 
supernatant was mixed with 1.0 ml of 0.67% TBA and 1.0 ml 
double distilled water, placed in a boiling water bath for 10 
minutes cooled and the absorbance of the colour was read at 535 
nm. The rate of lipid peroxidation was expressed as nanomoles 
of melonaldehyde (MDA) formed/30 minutes using extinction 
coefficient 1.56% x 10^ as described by Utely et al. (1967). 
3.17.3 Calculation : 
Lipid peroxidation was calculated using the formula ; 
Nanomoles of MDE formed/30 min X C D x 30 x 1000 x 1000 x 1000 x 3 x 2 
x= 
1.56 X 100000 x 1000 X 1800.D. x 10 
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Where, 
MDA = melonaldehyde 
O.D. = Change of optical density at zero hour and three hour 
incubation of the same samples. 
3.17.4 Statistical Analysis : 
The data were analysed using student's 't' test significant 
difference between means of treated and control groups were 
calculated and 'p' values were obtained. 
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RESULTS 
Two group (controlled and experimental) each of 6 male 
albino rats of the average weight 250 + 50 grams were separately 
taken for each steroidal derivative. Intraperitonial injection (0.3 
*mg of steroidal derivative dissolved in peanut oil/kg body weight) 
were given daily for 15 days, on 16th day animals were sacrificed 
for biochemical studies. The concentrations of total lipids, 
phospholipids, esterified fatty acids, cholesterol, gangliosides 
and rate of lipid peroxidation and cholesterol/phosphate ratio was 
determined in major brain parts cerebrum, cerebellum, brain stem 
and spinal cord. 
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Table-4( i ) 
EfTects of steroidal derivative on different regions of 
male albino Rat's CNS, injected 0.3 mg/kg for 15 days ip. 
'^ramelff 
Brain 
Ports 
Srou Structure - oclivity - corelolion 
keto ocetay-5-er^e ocetoxy - nilro ocetoxy -
G 
A 
N 
G 
L 
I 
0 
s 
I 
D 
E 
S 
CBM 
c 1.19i0.19 1.1940.19 1.19^0.19 
Ex 
US US 
1.4140.14 1.4610.13 
% IS.04 18.80 23.02 
CBL 
c 0.6S«0.S9 0.6S40.S9 0.6540.59 
u 0.98^0.89 l!294i0.13 1.041310.1 1 
% 
S2.S2 100.77 61.56 
BS 
c 0.331.32 0.3340.32 0.3310.32 
Ex 
• • • 
0.6610.S9 
• • • 
0.5940.05 
• • • 
0.5210.49 
% 100.12 81.51 56.57 
SPC 
c 0.3040.29 0.3040.29 0.3010.29 
c» 
NS 
0.^7*0.27 0.5fii0.03 0.1610.15 
'h -9 .43 -2.35 -54 .90 i 
(mg^g issue, mean ± S.D.) 
C = control. Ex = Experimental; % = Percentage 
3 d-Acctoxy-cholest-5-cne (aceloxy-5-ene) 
3 6 - Acetoxy-6-nitro-cholcst-5-cne (acetoxy-nitro) 
3 6 - Acetox>-5a-choIestan-6-one (acetoxy-keto) 
Values •? < 0 05 , • •? < 0 01 ; •••P<^ 0^ 001 
NS = Not Significant 
4.1: TABLE-4(I) 
Acetoderivative produces significant increase In the level 
of gangliosides in brainstem (100.12%), and cerebellum (52.52%). 
It produces an insignificant rise in spinal cord (9.43%) and decrease 
• In cerebrum (15.04%) . 
Aceto-nitro derivative produces significant increase in the 
concentration of gangliosides in cerebellum (100.77%) and brain 
stem (81.51 %), whereas insignificant rise (18.80%) is observed in 
cerebrum and depletion in spinal cord (2.35%). Significant rise in 
gangliosides level is also observed with the treatment of aceto-
nitro derivative in cerebellum (61.5%), brain stem (56.57%) and 
cerebrum (23.02%), Whereas significant depletion of 54.9% is 
observed only in spinal cord. 
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Tab le - ( i i ) 
EfTecls of steroidal derivative on different regions of 
male albino Rat's CNS. injected 0.3 mg/kg for 15 days ip. 
Parameter 
Brain 
Ports 
3rou Structure - activity - corelotiort | 
ocetoocy-S-ene oceloxy - nitro ocetoxy - keto 
T 
0 
T 
A 
L 
L 
1 
P 
1 
D 
S 
CBM 
c 87 .15^8 .70 78 .15+8 .70 87 .15+8 .70 
Ex 80.5f+^8.02 79 .? l+ .7 .72 147.00+14.52 
% 
- 7 . 9 7 - 8 . 2 7 3 68 .67 
CBL 
C 49 .21+4 .70 49 .21+4 .70 49 .21+4 .70 
.£x 73!99+7.28 1 0 6 ! l 4 + 1 0 . 5 1 5 5 ! 9 6 i l 4 . 3 9 
7i 50.36 115.68 216 .927 
BS 
C 190.76+10.36 109 .67+10.3« 109 .76^1036 
.£K 30.73+3.06 70 .25^7 .0 84 .65+7 .90 
7f - 3 2 . 5 9 - 3 5 . 9 9 - 2 2 . 8 8 
5PC 
-C 170.12+15.34 170.12+15.34 170 .12+15.34 
,E'« 150 .^ f+15 .01 200.8S+18.01 1 8 8 . ? f + 1 6 . 9 
Jl, - 1 1 . 4 0 9 1 17.564 1 0 . 8 1 
(mg/g issue, mean ± S.D.) 
C = control; Ex = Experimental; % - Percentage 
3 B-Acctoxy-cholest-5-ene (acetoxy-5-ene) 
3 B - Ac€toxy-6-nitro-cholest-5-cne (acetoxy-nitro) 
3 B - Acttoxy-5a-cholestan-6-one (acetoxy-keto) 
Values : •? < 0.05 ; ••? < 0 01 ; •••P<0.001 
NS = Not Significant 
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4.2: TABLE-4(1I) 
Table-4 (II) shows the effect of three steroidal derivatives 
(3-p-acetoxy cholest-5-ene; 3-p-acetoxy-6-nitro cholest -5-ene; 
31i-acetoxy-5a-cholestan-6-one) on the total lipid concentration i; 
rats brain. The acetoxy-keto derivative produces significant 
increase of 68.67% in the cerebrum and 216.927% in the 
cerebellum, while insignificant 10.81% increase in the spinal 
cord. Significant decrease of 22.88%, in the total lipid contents is 
observed in the brain stem. 
The acetoxy-nitro derivative produces significant 115.68% 
increase in the total lipid contents of cerebellum. 
Insignificant increase (17.56%) occurs in the spinal cord 
and decrease in cerebellum. Brain stem shows significant 
35.99%decrease in the total lipids concentration. 
Acetoxy derivative produces Insignificant decrease of 7.97% 
and 11.41% in the concentration of total lipids In cerebrum and 
spinal cord. A significant rise of 50.36% is observed In cerebellum 
and insignificant decrease of 32.59% in brain stem. 
"V - i f 
I : 
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Table-4(iii) 
Effects of steroidal derivative on different regions of 
male albino Rafs CNS, injected 0.3 mg/kg for 15 days ip. 
Urometer 
Brain 
Ports 
jrou Structure - activity - corelolion 
ocetoxy-S-ene occtoxy - nitro ocetoxy - keto 
E 
5 
T 
E 
R 
1 
F 
1 
E 
0 
f 
A 
T 
T 
y 
A 
c 
1 
D 
S 
CBM 
(i ft.72^0.is ft. 7240.«> ft.7240.ftS 
Ex 14! l7*1.13» 7.2l40.7ft 
• •• 
18.ft44l.79 
% 110.65 14.32 177.28 
CBL 
c 9.oi3«o.ao 8.01340.80 8.01340.80 
.u 13To724l. l3 19^8941.89 
• •• 
13.8341.3 
\ «3.134 148.22 72.59 
as 
c IS.48401.S IS.48401.5 15.4841.5 
.El 9.4S4.82 I S . f i f l . S S 10.4141.09 
% -38 .73 0.8 -32.8 
SPC 
c 20.35«2.03 20.3S42.03 20.3542.03 
^ 10.3041.02 
• •• 
9.17S40.89 ft.9234^.572 I 
A - 49.43 1 -54.923 -ft5.98 1 
(mg/g issue, mean ± S.D.) 
C = control; Ex = Experimental. •/© = Percentage 
^ B-Acetoxy-cholest-5-ene (acetoxy-5-ene) 
^ B - Aceioxy-6^iitro-choIest-5-ene (acetoxy-nitro) 
3 0 - Acetoxy-5a-cholestan-6-one (acetoxy-ketok^v^-' 
Values *P < 0 05 ; • • ? ^ 0 01 . • • •P<0 001 £, r^ 
NS = Not Significant 
WHiBPi 
" . * 
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4.3: TABLE-4(lin 
Table-4 (III) shows the significant rise In the concentration 
of esterlfied fatty acids In cerebrum (110.65%), and cerebellum 
<63.134%) induced bythe administration of aceto-derivatlve. This 
derivative produces an significant decrease in EFA in brain stem 
(38.73%) and spinal cord (49.43%). 
Aceto-nitro derivative produces significant rise in EFA 
concentration in cerebellum and significant decrease in spinal 
cord (54.923%) whereas insignificant rise is found in cerebrum 
(14.32%) and brain stem (0.8%). 
Aceto-keto derivative produces significant rise In the EFA 
concentration in cerebrum (177.28%), and cerebellum (72.59%). 
Significantly decreased level of 32.8% and 65.98% is observed in 
brain stem and spinal cord. 
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Table-4(iv) 
Lflccts of steroidal derivative on diflcrent regions of 
male albino Rat's CNS, injected 0.3 mg/kg for 15 days ip. 
1 Broin 
Ports 
3rou Structure - octivity - cortlotion 1 
^rometof ocetoqf-5-er« o c d o x y - nitro oonoKy • «r»w 
C 
H 
0 
L 
E 
S 
T 
E 
R 
0 
L 
CBM 
c 3.SI7«0.349 3.S87«0.349 S.S87*0.349 
Ex 2.1«.>0.209 2.7S.^0.29< 3.oS42.9f 
% 
-39.029 -22.91C - 1 4 . 7 
CBL 
c 1.7S2>0.1«9 1.752^0.1*9 1.7S2*0.1«9 
Ex l . /> t0 .1«3 3.70*0.297 3.10^0.301 
7t -1.096 111.223 
78.74 
as 
C 3.«340.32S 3.«340.32S 3.«3*0.32S 
Ex l.S5^0.109 7.17*0.(91 2.8340.28 
•/ i 
-«011S 97.93 -22.097 
5PC 
C 5.32«0.S21 S.3240.S21 S.32*0.S21 
Ex s.oeoi.492 «.tv*.S90 7.035^0.71 
. % -4.S11 28.711 32.24 
(mg/g issue, mean ± SD.) 
C = control; Ex = Experimental; % = Percentage 
3 B-Acetoxy-cholcst-5-ene (acetaxy-5-ene) 
3 B - Acelox) -6-nitro-choIest-5-eBe (acetoxy-nitro) 
3 fl - Acetox>-5a-choIestan-6-one(acetoxy-keto) 
Values : •? < 0 05 ; ••P < 0.01 ; •••P<0 001 
NS = Not Sipificant 
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4.4: TABLE-4(IV) 
Aceto-derivative produces a significant decrease in the 
concentration of cholesterol in brain stem. While in the rest of the 
other three major parts i.e. cerebrum, cerebellum and spinal cord. 
It produces a insignificant decrease of 39.029%, 1.096% and 
4.5% In the cholesterol level. 
Aceto-nltro derivative produces significant elevation in the 
cholesterol concentration in cerebellum (111.223%),spinal cord 
(28.718%) and brain stem (97.93%). It produces an insignificant 
deprivation In cerebrum (22.916%). 
Aceto-keto derivative produces significant Increase in the 
cholesterol level In cerebellum (76.74%), and In spinal cord 
(32.24%). Insignificant decrease In the cholesterol level is 
observed in brain stem (22.097%) and cerebrum (14.7%). 
bO 
Effects of steroidal derivative on diflercnl regions of 
male albino Rat's CNS. injected 0.3 mg/kg for 15 days ip. 
Urometer 
Brain 
Ports 
jrooi Structure - octivity - corelolion 
ocet0Ky-5-«n« ocetoxy - nitro cxetoxy - keto 
P 
H 
0 
S 
P 
H 
A 
T 
E 
CBM 
c 10.C04l.01 10.C04l.01 10.C04l.81 
Ex §.t2*0.»3 
• • 
C.87540.C4 
•s 
9.C2540.95 
f, -20.S7 -35.142 -9.198 
CBL 
.C S . 1 0 0 . 4 1 5.1440.41 S.1440.41 
Is 
MS 
S. 23^0.921 14.C2S4l.27 17.37541.53 
% 2.14 
184.53 238.035 
BS 
c «.344«0.S« «.34440.58 8.34440.58 
Xx 7.54^0.73 0.21540.02 • • • 15.2541.41 
Jh 22.399 -9C.S87 141.10 
SPG 
J : 11.0541.013 11.0541.01 11.0541.01 
&< • .S34.823 13.12541.30 
M S — — 
10.71741.C2 
J:& -22.770 -18.82 -3 .123 
(mg/g issue, mean ± S.D.) 
C » control; Ex = Experimental; % = PercenUge 
3 B-Acefoxy-cholcst-5-ene (acetoxy-5-cne) 
3 0 - Acetoxy-6-«tro-cholcsl-5-«nc (acctoxy-nitro) 
3 1 - Acetoxy-5a-cl»o!estan-6-one (acctoxy-kcto) 
Vklues : •? < 0.0$ , • •? < 0 01 . •••P<0 001 
NS = Not Significant 
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4.5: TABLE- 4 (V^ 
Following the administration of acetoxy-derivativephosphate 
level Is insignificantly decreased by 20.57% and 22.77% in the 
cerebrum and spinal cord. A significant enhanced level of 
phosphate is observed in cerebellum (50.36%) and insignificantly 
decreased value In brain stem (32.59%). 
Aceto-nitro derivative produces significant increase in the 
phosphate concentration in cerebellum (184.53%) and significant 
decrease in brain stem (96.587), cerebrum (35.14%) and spinal 
cord (18.82%). 
Aceto-keto derivative produces significant rise In the 
concentration of phosphate In cerebellum (238.04%), brain stem 
(14.10%) and insignificant decrease in the cerebrum (09.198%) 
and spinal cord (03.123%). 
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Table-4 (Vl) 
Effects of steroidal derivative on different regions of 
male albino Rat's CNS, injected 0.3 mg/kg for 15 days ip. 
Urometer 
Brain 
Port* 
jfXXi Structure - octivity - oortlolion | 
octlOKy>S-«ne occtoxy > nitra ooHoxy - kcto 
L 
1 
P 
1 
D 
P 
E 
R 
0 
X 
1 
0 
A 
T 
1 
0 
N 
CBM 
Q i.7»2*9.2t 3.78240.2S 3.78240.2* 
Ex 
MS 4.96S40.44 
•S 
4.4640.38 
% 17.t7 31.36 18.77 
CBL 
C 3.67*0.31 3.6740.31 3.674^0.31 
.In 
US 
4.i|17«0.39 MS 3.3S940.31 3.1440.23 
7i -14 .4t -8 .54 20.25 
BS 
C 1.3240.11 1.3240.11 1.3240.11 
£K 1.8940.13 
US 
1.35340.15 
• • 
1.79540.09 
Jh 43.1S1 2.42 35.88 
SPC 
.C 1.67»40.13 1.679«0.13 1.67940.13 
^ 
1.9140.12 
NS 
1.64840.11 US ' • 1.3440.10 
Jk 13.75 -1 .84 -20.19 
(mg/g issue, mean ^ S D ) 
C = control; Ex = Experimental. % = Percentage 
3 B-Acetoxy-cholcst-5-cne (acctoxy-5-cnc) 
3 6 - Acetoxy-6-«tro-cholest-5-ene (acetoxy-nitro) 
3 6 - Acetoxy-5a-cl»oIeslan-6-onc (acctoxy-keto) 
VUucs : •? < 0 05 ; **? < 0 0| ; •••P«^0 001 
NS = Not Significant 
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4.6: TABLE-4 (Vn 
Table-4 (VI) shows the data obtained for the rate of lipids 
peroxidation following the administration of three steroidal 
derivative. 
Aceto-derivative produces only significant enhancement of 
43.15% In brain stem, while in cerebrum (17.97%) and spinal cord 
(13.75%) insignificant rise is observed. Only insignificant depletion 
of 14.48% reported in cerebellum of rats brain in the study. 
Aceto-nitro derivative shows only significant rise of 32.36% 
in cerebrum and insignificant rise of 2.42% in brain stem. In 
cerebellum and spinal cord this derivative produces insignificant 
depletion of 8.54% and 1.84%. 
Aceto-keto derivative produces significant rise in the rate of 
lipid peroxidation in brain stem (35.88%) and cerebellum (20.25%) 
while insignificant rise is observed in cerebrum and depletion in 
spinal cord (20.19%). 
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TABLE - 4 V I I ) 
Effects of steroidal derivative on different regions of 
male albino Rat's CNS, injected 0.3 mg/kg for 15 days ip. 
Porometer 
Broin 
Ports 
&rou] 1 Structure -octivity- coreiotiort 
ocetOKy-5-ene ocetoxy - nitro ocetoxy - keto 
C 
H 
0 
L 
E 
5 
T 
E 
R 
0 
H 
0 
S 
P 
H 
A 
T 
E 
RATIO 
CBM 
Q 0.338 
0 .338 0.338 
Ex 
0.259 0 .402 0.318 
% 
- 1 . 8 9 8 - 0 . 6 S 2 - 1 . 5 9 8 
CBL 
C 
0.341 0 .345 0.341 
In 0.330 0 .253 
0.1784 
7i 
- 0 . 5 1 2 0 .662 0.322 
BS 
c - 0 . 5 7 2 0 .572 0.572 
E?( - 0 . 1 5 0 3.34 0.185 
•/, - 3 . 0 4 1 - 1 . 0 1 3 - 0 . 1 5 6 
5PC 
C 2.385 2 .385 2.365 
Ex 0.596 0 .522 0.656 
•/• - 0 . 1 9 6 - 1 . 2 6 2 - 1 0 . 3 2 3 
(mg/g issue, mean ± S.D.) 
C = control. Ex = Experimental ; % = PcrccnUge 
3 6-Acetoxy-cholest-5-cne (acctox>-5-cnc) 
3 B - Acetox>-6 nitro-cholest-S-cnc (acetoxy-nitro) 
3 fi - Acctoxy-5a-cholcstan-6-one (acctoxy-lccto) 
Values •? < 0 05 , • •? < 0 01 ; •••P<0.001 
NS = Not Significant 
4.7: TABLE-4(V1I) 
Table-4 (VII) is a list of cholesterol/phosphate ratio with 
respect to the steroidal derivatives. Aceto-derivatlve shows a 
negative values of the ratio in alt four brain parts I.e. cerebrum 
(1.898%), cerebellum (0.612%), brain stem (3.041%) and spinal 
cord (0.198%). 
Aceto-nitro derivative shows the negative value of c/p ratio 
In cerebrum (0.652%), brain stem (1.013%) and spinal cord 
(1.262%), the only positive value is observed in cerebellum. 
Aceto-keto derivative shows negative values of c/p ratio in 
cerebrum (1.598%), brain stem (0.156%) and spinal cord (10.323%) 
while positive value is calculated in cerebellum (0.322%). 
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5. DISCUSSION : 
5.1 GANGLIOSIDES : 
Gangliosides are the sialic acid containing 
glycosphingolipids, which are highly enriched in the CNS of 
vertebrate, including man (Wiegandt 1967; Ledeen 1978; 
Svennerholm 1980; Rahman,1983). Sialic acid is the generic 
name for N-acylneuraminic acid, and the acyl group of sialic acid 
in the human brain is always the acetyl form (Suzuki 1981). N-
acetyl neuraminic acid is commonly abbreviated as Neu Nac. 
Gangliosides are localized in two fraction of the brain. Major 
gangliosides of the brain are GM1, GM2, GM3, GD1a, GD1b and 
GT and other minor are GD3, GD2 and slalylagal actosylceramide 
are also present. 
Synaptosomal or myelin membranes in the form of liposomes 
or microbial cell wall and membrane fragments containing repeatinc 
arrays of gangliosides or cross-reactive Glycoproteins may be 
able to activate B-cells in this way (Pestronk, 1991). 
Gangliosides undergo characteristic changes in content 
and composition during development (Rosner, 1977, Engel et al. 
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F i g : - 5.1 
Gangliosides 
• Control 
3 - p - acetoxy-cholest-5-ene 
3-^-acetoxy -8 -n i t ro -cho ls t -
5 - ene 
3 -p -ace toxy -5 - t -cholestan-
6 - one 
P Values: - p< 0 05 
. . p<001 
. . . p<0 001 
N5 = Not Significant 
Cerebrum Cerebellum Brainstem Spinal cord 
Regional alteration in the levels of gangliosides 
in different regions of rat CNS following the 
administration of 3 - p - acetoxy-cholest - 5 -ene. 
3 - p - acetoxy - 6-nitro - cholest - 5-ene, 3 -p -
acetoxy - 5-oC - cholestan - 6 - one, -3 mg/kg body 
weight ip for 15 days. 
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1979, Yusuf and Dickerson 1980) and have, therefore, been 
suggested to be instructed molecules for brain maturation. In 
particular they appear to be functionally involved in the control of 
axonal (Willinger and Schachner, 1980) and dendritic (Irwin and 
IrwinJ 979) out grov^ h^ synaptogenesis (Engel et al.,1979) and the 
establishment of cell contact (Yogeeswaran and Hakomori,1975). 
More over in adult nervous system, the Individual gangliosides 
have been suggested to play a role as membrane bound receptors 
or co-receptors for toxins, drugs viruses hormones transmitters 
etc. (Svennerholm 1980). 
Gangliosides are generally synthesized in neuronal perikarya 
and are transported to the nerve ending alongwith macromolecules 
(Rahmann and Rosner, 1973; Ledeen et al. 1976; Landa et al., 
1979). Local synthesis within the axons and nerve endings 
(Ledeen et al. 1976) or even at the plasma membrane level (Preti 
et al.,1980) can not be excluded. Gangliosides are involved in 
nerve impulse conduction since they act as receptor sites for 
neurotoxins (North et al.,1961; Rahmann et al. 1982). Irwin and 
Samson (1971) reported that certain types of behavioral 
stimulations (stress, sensory stimulation, learning, exercise) seem 
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to be accompanied by alterations in Gangliosides metabolism. 
Mental retardation and neurological dysfunction are major signs 
in nearly all the lipid storage diseases, apparently because of 
abnormal deposition of the different glycosphingolipids in the 
CNS due to defective disorders in degradatiye enzyme pathways, 
resulting in retardation of development, paralysis dementia and 
blindness (Lehninger^1984). Biosynthesis of brain gangliosides 
occurs by sequential addition of monosacharides or N-
acetylneuraminic acid to the carbohydrate chain, starting from 
ceramide. Degradation of brain gangliosides proceeds by 
sequential removal of monosacharides and Neu Nac (N-
acetylneuraminic acid) by glycosides and neuraminidases (Ledeen 
et al., 1973, Ledeen and Mcllanby 1977, Suzuki, 1981). 
Gangliosides are responsible for the humeral immune 
response (Willson H.J. and Kennedy,1993) evidences accumulated 
throughout the 1980s indicate the humoral immunity to gangliosides 
is frequently observed in patients with chronic demyelinating 
peripheral neuropathies (Lotov, 1990) for example Guillain Barre 
Syndrome a (Willison and Kennedy, 1993). 
The Gangliosides mixture of bovine brain gangliosides 
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(GM1, GDla, GD1b, GT1b) has been widely used in trials of the 
treatment of peripheral neuropathies (Hallett et al.,1987). 
Gangliosides have been used for treatment of various 
degenerative, toxic and metabolic neuropathies in Europe although 
their efficiency remains controversial (Bradley, 1990). Patients 
with multifocal motor neuropathy have high titer serum antibodies 
against the Gangliosides GM1 (Pestronk 1991). In lewis rats, 
myelin induced experimental allergic neuritis or animal model of 
human acute Gullian Barre Syndrome can be depressed and 
delayed by adding Gangliosides mixture (GM1, GDla. GDIb, 
GTIb) to the immunization compound. However, gangliosides 
may enhance the induction of adjuvant arthritis sinceeyternally 
applied gangliosides produce antibodies (Weietholter, H. et al.^  
1992). 
Studies on gangliosides had been done earlier in our 
laboratory. Intramuscular administration of 100 pg estrogen daily 
for 30 days to female rabbit was followed by decrease in 
gangliosides in cerebellum and spinal cord while an elevated 
level was observed in cerebral cortex and brain stem (Islam et al., 
1984). 
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There is no previous report on the classified study on 
structure activity co-relation on the level of gangliosides in the 
central nervous system while using three derivatives of cholesterol 
(1) 3-B-acetoxy-cholest-5-ene (2) 3-B-acetoxy-6-nitro-cholest-5-
ene, (3) 3(i-acetoxy-5a-cholestan-6-one. In the present study 
changes were found as following in the cerebrum, cerebellum, 
brain stem and spinal cord. 
When the activity of acetoxy, acetoxy-nitro and acetoxy-
keto group was measured in the different brain parts of male 
albino rat following the administration of 0.3 mg/kg body wt. 
Injections of the steroids for 15 days, gradual rise in the 
Gangliosides contents from the effect of acetoxy to acetoxy-keto 
group is reported in the cerebrum. Only a slight increased is 
estimated with the administration of acetoxy-keto derivative in 
cerebrum. 
In the cerebellum all the three derivatives induce significant 
rise in the gangliosides content. Maximum rise is reported in this 
study with acetoxy-nitro derivative in cerebellum (100.78%). 
Estimation of gangliosides in the brain stem shows significant 
rise in its contents. Whereas in spinal cord all the three steroid 
induce depletion in gangliosidescontents, among these three 
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steroids only acetoxy-keto derivative induces significant depletion 
in spinal cord. 
Effect of acetoxy derivative is maximum in brain stem, whereas a 
significant rise in the Gangliosides content (100.12%) is reported,in 
the cerebellum a significant change but less than from spinal cord 
is reported. A Insignificant change is observed in the spinal cord. 
Changes In the gangliosides contents by acetoxy-nitro compound 
is reported significantly high in the cerebellum comparable to the 
brain stem, while in cerebrum insignificant rise Is reported. In the 
case of spinal cord minimum -2.3% depletion is reported. 
Acetoxy-keto derivative is the most active in the cerebellum 
where a significant maximum enhancement in the gangliosides 
content is reported (61.56%) in this study. 
5.2 TOTAL LIPIDS : 
The Major structural and functional constituents of biological 
membrane are lipids, they also serve as essential component of 
several crucial enzyme systems,as fuel molecules, and as highly 
concentrated energy store (Lehninger, 1984). In mammalian central 
nervous system, lipids comprise over half of the total dry weight 
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Fig : - 5.2 
Total Lipids 
Cereb rum Cerebellum Brain stem Spinal cord 
Regional alteration in the level of total lipids 
•n different regions of rat CN5 following the adminis-
tration of 3 -p -acetoxy-cholest -5 -ene , 3 ^-acetoxy-
6-nitro - cholest-5 ene. 3-P-acetoxy - 5-iC-cholestan-
6- one. -3 mg/Kg lx)dy, weight ip for 15 days. 
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(Suzuki, 1981). Almost all the lipids in CNS are found in membranes 
of cells. Different types of membranes accumulate different types 
of lipids. These brain lipids are constantly being synthesized 
replacing other molecules In the membranes (Horrocks et al.^  
1975). Lipids in the brain modulate the structure fluiding and of 
function of the biomembrane (Bourre et al. 1990). 
The brain lipids constitute components of ion channels and 
On 
neurotransmitter receptors, the other hand. They are also major 
constituents of myelin (Schinizu, 1965). Lipids In the brain makes 
upto 65% of the dry weight of the white matter and 34-40% of gray 
matter (Brante, 1949). Distinct regional differences occur in lipid 
contents, turnover in cell types and various path ways and centers 
of the brain (Ordy and Kaack, 1975). 
Changes in the level of total lipids in the brain may occur by 
various physiological, psychological and chemical stressors and 
ageing (Horrocks et al.,1981; Story et al.,1976). Changes in lipid 
fractions are induced by the steroids estrogen and progesterone 
in discrete brain parts as reported by Islam et al. (1980). 
In the present study an attempt has been made to study the 
elevation and deprivation in the level of total lipids in the various 
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parts of brain in albino rats . As far as the survey of literature is 
concerned, no previous report on the structure activity relation 
ship of various derivatives of cholesterol on the brain lipid profile 
js available follov i^ng the administration of three derivatives of 
cholesterol (I) Aceto- derivative (11) Aceto-nitro derivative and (iii) 
Aceto-Keto derivative, Injected ip 0.3 mg/kg body wt for 15 days 
in male albino rats. 
Total lipid contents were found insignificantly depleted with 
the administration of Acetoxy and acetoxy-nitro derivatives of 
total lipid contents in the CNS induced by acetoxy keto derivative, 
which is 68.67% significant rise. 
In this study changes in the total lipids induced by the three 
derivatives of cholesterol having (1) Acetoxy group (2) Acetoxy-
Nltrogroup and (3) Acetoxy-Keto. Effect of these derivatives were 
measured In the four parts (1) Cerebrum (2) Cerebellum (3) brain 
stem and (4) Spinal Cord. In the cerebrum Total lipids contents 
were found insignificantly depleted with the administration of 
acetoxy and acetoxy-nitro derivatives comparable to the observed 
values of total lipids content In CNS induced by acetoxy-keto 
derivative which gives 68.67% significant rise. 
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In the cerebellum gradual significant rise was observed 
following the administration of acetoxy, acetoxy-nitro and acetoxy-
keto derivative respectively. 50.36% maximum significant rise 
was estimated with the Acetoxy derivative. 115.68% significant 
rise was observed with the Acetoxy-nitro derivative and 216.93% 
significant rise was observed with the Acetoxy-keto derivative. 
In brain stem administration of Acetoxy and Acetoxy-nitro 
derivatives of cholesterol results in the significantly and steady 
decrease in the total lipid contents. -32.59% and -35.99%, with the 
acetoxy-keto derivative a decrease of -22.88% was estimated. 
In the spinal cord effect of these three cholesterol derivatives do 
not altersthe total lipid contents upto a significant level. However 
acetoxy derivative gives the decreased value of total lipid contents 
in spinal cord -11.40% whereas acetoxy-nitro derivative and 
acetoxy-keto derivative give a insignificant rise in the total lipid 
contents 17.56% and 10.81%, respectively 
Activity of 3-B-acetoxy-cholest-5-ene in four brain parts 
gives the decreased value of total lipid contents (brain stem -
32.59% > Spinal Cord -11.49% > Cerebrum -7.97%). In cerebellum 
it gives a significant high value of total lipids contents (50.36%). 
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Activity of 3-(i-acetoxy-6-nitro-choIest-5-ene in the four brain 
parts gives the trand that: 
Cerebellum (115.68%) > Spinal Cord (17.66%) while decreased 
values of total lipid contents is in the order, brain stem (-35.99%) 
> Cerebrum (-8.27%). 
Activity of 3-B-acetoxy-6a-cholestan-6-one gives the rising 
trend oftotal lipid contents as Cerebellum (216.92%) > Cerebrum 
(68.67%) > Spinal Cord(10.81%). Whereas In the brain stem it 
gives a -22.88% reduction in the total lipids contents. 
Changes In the lipid contents and lipid composition must be 
due to changes in rates of anaboiism, catabolism or these 
processes are controlled by the activities of appropriate enzymes 
Hazzard and co-workers (1969) have suggested that a reduced 
lipoprotein lipase activity may be a factor contributing to the 
increased plasma lipids. 
Depletion of unsaturaed lipids is associated with alteration 
in membrane fluidity (Bruch and Thayer, 1983) and the changes in 
the activity of membrane bound enzymes and receptors (Bobik 
et al.^  1983). Polly unsaturated fatty acids are by themselves, 
capable of causing damages to the cell membranes, tissues and 
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may contribute to the postraumatic decline in the blood flow as 
well as reactive unflammatory responses (Panter and Faden, 
1992). Interestingly lipids of various tissues are known to be in a 
dynamic steady state and there is continuous replacesment of 
existing molecules by newones (While et al. 1978). Present study 
reveals the effect of three different derivatives of cholesterol on 
the lipid contents of various parts of CNS. is different on each part. 
Earlier it was concluded by the study of Islam et al. (1984) that 
estrogen affects the lipid contens differentially In the various 
parts of the brain. 
6.3 ESTERIFIED FATTY ACIDS : 
Sahani and Patel (1974)] have reported a significantly 
depleted levels of the serum esterified fatty acids (EFA) in women 
taking 0.5 mg megesterol acetate daily at the interval of 3 and 6 
months. There is no previous report on the classified study on 
structure activity co-relation on the level of esterified fatty acid in 
central nervous system while using the different derivatives of 
cholesterol having different functional groups I.e. Acetoxy, Acetoxy-
nitro. Acetoxy-keto at certain positions on cholesterol molecule. 
However Islam et al. (1980) analysed the estrogen induced 
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Fig: - 5.3 
Esteritied Fatty Acids 
Cerebrum Cerebellum Brainstem Spinal cord 
Regional alteration in the level of Esteritied 
fatty acids in different regions of rat CN5 following 
the administration of 3-p-acetoxy - cholest-5ene, 
3 - p - acetoxy - 6- nitro -cholest- 5 - e n e , 3 - 3 - acetoxy-
5 - ^ - cholestan- 6-one,-3 mg/ kg body weight 
for 15 days. 
100 
changes in the level of lipids at microlevel In discrete brain areas 
of Rabbit Brain, when the primovlar (Ethinyl Estradiol) oral 
contraceptive was injected i.m. for 60 days,a significant decrease 
in EFA in hypothalamus, hippocampus and gyrus cinguli was 
observed. When estrogen was administrated I.m. for 30 days in 
Rabbit, a significant depletion in the EFA was observed in 
hypothalamus, hippocampus cerebral cortex, and cerebellum and 
a significant increase in the level of EFA was observed in midline 
nuclei of thalamus and at factory bulb. In another study Islam et 
al. (1984) explored the significant depletion in EFA le al in 
cerebral cortex and cerebellum following the intramuscular 
administration of 100 pg estrogen daily for 30 days in female 
rabbit. The concentration of EFA also depends upon the contents 
of the fatty acids present in tryglyceride and phospholipid (Stern 
and Shapiro, 1953). A significant increase in concentration of 
phospholipid is also a contributory factor for the increment in the 
contents of EFA. 
Following the administration of acetoxy, acetoxy-nitro and 
acetoxy-keto for 15 days in male albino rats changes in EFA 
contents in cerebrum was found significantly high, with acetoxy 
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derivative 110.65% and with acetoxy-keto derivative it w/as 
177.2%, whereas with the acetoxy-nitro derivative a insignificant 
rise of 14.33% was detected in cerebrum. 
Acetoxy derivative proves itself a less active than acetoxy-
Xeto derivative while both of these are less active than acetoxy-
nitro derivative in cerebellum. Alteration In the EFA estimated was 
significantly high 63.14%, 72.59% and 148.22% respectively with 
acetoxy, acetoxy nitro and acetoxy-keto derivatives. Activity of 
these three derivatives on brain stem shows significant depletion 
with acetoxy and acetoxy-ketoderivative whereas acetoxy-nitro 
derivative gives almost negligible change (.85%) in brain stem. 
In the spinal cord, significant depletion in the EFA is reported with 
all the three derivatives of cholesterol. Activity Is in the order, 
acetoxy-keto derivative is most active than acetoxy-nitro derivative 
> acetoxy derivative, (-65.98% > -54.92% > -49.43% respectively). 
While analyzing effect of acetoxy derivative separately on brain 
parts, data reveals the maximum significant enhancement in the 
EFA contents in cerebrum (110.65%) and in cerebellum significant 
Increase but lesser than cerebrum (63.13%). Acetoxy derivative 
Induces significant depletion in the EFA in spinal cord and brain 
stem (-49.43%) and (-38.72%). 
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Induction of the changes by the acetoxy-nitro derivative in 
the brain parts shows increase in the EFA in cerebrum, cerebellum, 
brain stem, and depletion in the spinal cord. Significant increase 
in the EFA is maximum in cerebellum 148.22% while insignificant 
increase is in the cerebrum and brain stem. Acetoxy-nitro derivative 
adversely effects to the spinal cord where a significant depletion 
In EFA is reported (-54.92%). 
Changes by acetoxy-keto derivative in the brain parts shows 
maximum significant increase in EFA in cerebrum is 177.28%, 
72.59% significant increase is reported in cerebellum, while in the 
brain stem and spinal cord a significant maximum depletion is 
reported. 
Maximum significant increase in the EFA contents is found 
in the cerebrum induced by the acetoxy derivative and maximum 
significant depletion is reported in the spinal cord. Maximum 
significant increase in the EFA contents is observed in the 
cerebellum induced by the acetoxy-nitro derivative and maximum 
significant depletion in the spinal cord. 
Effect of acetoxy-keto derivative Is maximum comparable to 
the effect of rest two derivatives in the EFA contents In cerebrum 
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whereas and in the spinal cord a nfiaximum depletion in EFA is 
reported in this study. 
5.4 CHOLESTEROL : 
Cholesterol is a major and only sterol, present In the 
significant amount in the central nervous system [(Ansell and 
Hawthorne, 1964)]. It Is also an important component of biological 
membranes. Membranes are generally thought to consist of 
phospholipid bilayers Into which membrane proteins are embedded, 
yet cholesterol molecules are present in most animal structures. 
Due to its amphlpathic nature bearing an OH-group and a 
hydrocarbon skeleton with rigid rings and a branched chain of 
eight carbons, cholesterol is perfectly suited to mesh with lipid 
bilayers [(Brenner, 1990)]. 
Cholesterol accounts for about 10% of dry weight of the 
brain in contrast to less than 1% found in most other organs. The 
constancy of the amount of cholesterol In the brain suggests that 
the sterol is metabolically stable [(Waelsch, et al, 1940)]. 
Unesterified cholesterol has been suggested as a lipid 
characteristic of myelin sheath, as it occurs in white matter in a 
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Fig: - 5.4 
CHOLESTEROL 
Cerebrum Cerebellum Brain stem Spinal cord 
Regional alterations in the levels of cholestrol 
following the administration of 3 -p-acetoxy-
cholest - 5 - ene. 3 - p - acetoxy - 6 - intro - cholest -
5-ene. 3 - p - acetoxy-5-1- cholestan-6- one/3mg/ 
Kg body weight \P for 15 days in the different 
regions of rat CN5. 
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higher concentration than in gray matter [(Johnson, 1949; Brante, 
1949)]. About 25% of cholesterol is present in myelin lipid by 
weight [(Soto et al. 1966)] and approximately 70% of total brain 
cholesterol is present in myelin [(Laatsch et al. 1962)]. Cholesterol 
is thought to act as a convenor in the absorption of fats. [Bloor 
(1943)] reported a parallelism between cholesterol content of 
blood and the fatty acids. Due to the abundance of cholesterol in 
nervous tissues and its variation in mental diseases, it may 
function as an insulating medium for myelin sheaths. Sterols are 
thought to have a role in maintaining the balance between the cell 
permeability and the membrane equilibrium of living cells. Brain 
microsomes are the sites of cholesterol biosynthesis [(Paoletti, 
1971)]. Cholesterol is synthesized from acetate and precursors 
via mevalonic acid. Both the biosynthesis and the deposition of 
cholesterol in the CNS is most rapid. Biosynthesis of cholesterol 
in brain is most rapid during active myelination, but adult brain 
retains the capacity to sythesize cholesterol when precursors, 
such as acetatic or mevalonate are available. 
Fatal or neonatal brain prior to myelination contains relatively 
little cholesterol. [Kritenevesky and Holmes (1962)] found varying 
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amounts of the sterol in the newborn rat brain. In rat brain, total 
levels of sterol ester increase from birth to 40 days [(Eto and 
Suzuki, 1972)]. A decline is also noticed in human and guinea pig 
brain cholesterol (62.3%) and denosterol (31.1 %), The major 
sterol and small to trace amounts of other sterols were also 
detected [(Ramsey and Nicholas, 1972)] relative to total 
phospholipid and glycolipid, in which changes in whole brain and 
myelin are compared. Earlier studies in our lab on the alteration 
in cholesterol level following the intramuscular administration of 
ethinylestradiol and 0.5 mg norgestrel on the regional lipid levels 
of cholesterol was found decreased in hypothalamus, 
hippocampus, amygdaloid nucleus midline nuclei of thalamus and 
gyrus cinguli (Islam et al. 1980). He observed a depleted level of 
cholesterol in brain stem and spinal cord but it was elevated in 
cerebellum, following the ip administration of estrogen in female 
rabbit. 
In the present study three derivatives of cholesterol 3-B-
acetoxy-cholest-5-ene, 3B-acetoxy-5a-cholestan-6-one were 
injected in the 3 groups of male albino rats (.3 mg/kg body wt i.p. 
for 15 days) changes in the cholesterol level estimated in the 
cerebrum, cerebellum brain stem and spinal cord. 
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However, no systematic work on structure-activity co-relation 
is done so far on the various homologues of cholesterol on the 
brain. Earlier Islam et al., 1980 has studied the effect of estrogen 
and primovlar (Having slight difference in the structure). Cholesterol 
level In the estrogen treated rabbits in the Islam's study show 
regional heterogeneity in exhibiting a depletion In the brain stem 
and spinal cord and increase in the cholesterol level in the 
cerebellum following 30 days administration. 
Primovlartreated rabbits showsthe depletion of cholesterol 
level in hippocampus, amygdaloid nucleus, midline nuclei of the 
thalamus and gyrus Cinguli in his study. Islam also noted that 
alteration of cholesterol level was only significant after 90 days 
administration of primovlar treatment. In the primovlar treated 
rabbits, the highest variation of the cholesterol contents in the 
control and midline nuclei of the thalamus, while the content of 
cholesterol remain unchanged in hypothalamus, hippocampus 
and mygloid nucleus. 
In the present study effect of the three derivatives were 
evaluated In the CNS of albino rats activity of these steroids in the 
cerebrum is as following : 
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Among the acetoxy, acetoxy-nitro and acetoxy-keto 
derivative, acetoxy derivative and acetoxy-nitro derivative give 
the -39.02% and -22.91% significant depletion in the cerebrum 
whereas acetoxy-keto derivative gives -14.7% Insignificant 
depletion in the cerebrum. 
In the cerebellum acetoxy-nitro derivative gives the maximum 
significant increase of 111.223% while acetoxy-keto derivative 
gives 76.74% significant increase. Whereas acetoxy derivative 
gives an insignificant depletion in the cholesterol level. 
In the brain stem activity of acetoxy-nitro group gives 
maximum significant rise In the cholesterol level (97.93%). Acetoxy 
derivative gives the significant depletion In the cholesterol level 
in brain stem. On the other hand Acetoxy-keto derivative gives an 
insignificant depletion in the cholesterol level in brain stem. 
In the spinal cord, effect of acetoxy-keto derivative gives the 
maximum significant rise In the cholesterol level (32.24%). 
Acetoxy-nitro derivative gives the significant (28.71%) rise in the 
cholesterol level. While an insignificant depletion is reported with 
the acetoxy derivative of cholesterol. 
Analysis of the effect of acetoxy-derivative on all the four 
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brain parts reveals its maximum effect on brain stem, whereas in 
the cerebrum, effect is insignificant in the cerebellum and spinal 
cord. In all the four brain parts acetoxy derivative induces depletion 
in the cholesterol level. 
Analysis of the effect of Acetoxy-nitro derivative on the 
different parts of the brain reveals Its maximum effect on cerebellum 
than in brain stem, a significant rise but lower than cerebellum and 
brain stem is reported in spinal cord, this compound whereas 
gives a significant depletion in the cerebrum. 
The activities of acetoxy-keto derivative shows the significant 
rise in the cholesterol level in the cerebellum and spinal cord 
(76.74% and 32.24%) Whereas an insignificant depletion in the 
cholesterol level in the cerebrum and brain stem reported in this 
study. 
A comparison in the activity of all the three derivatives 
reveals that acetoxy derivative exert its maximum effect on brain 
stem and induces depletion in the cholesterol level. Acetoxy-nitro 
group induces maximum significant rise in the cerebellum and 
also maximum depletion In the cerebrum. Acetoxy-keto derivative 
induces maximum significant rise in the cerebellum and 
insignificant maximum depletion in brain stem. 
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5.5 PHOSPHOLIPIDS : 
Phospholipids are the major class of membrane lipids 
(Holkin, 1969, white 1973). These forms the backbone of neural 
membranes and also provide the membrane with suitable 
permeability (Farooqui and Horrocks, 1985, Procellati, 1983). 
Glycero phospholipids are the major component of brain lipids 
phospholipids constitute approximately one fourth (20-25%) of 
the dry weight of brain (Holkin, 1969, White 1973). Total amounts 
of phospholipids are higher in white matter than in gray matter, 
and the reported amounts range from 3 1-4.6 g/100 g fresh for 
gray matter and 6.2-9.3 g/100 g for white matter (Suzuki-1981). 
The distribution of phospholipids in biogenic membranes is 
regulated not only by the activity of enzymes invol\'jd in their 
metabolism but also their transport and incorporation processes 
Into membranes. Enzymes of neural membranes liberate free 
fatty acids, acyl-COA, diglycerides and lysophospholipids. Under 
normal conditions, such metabolites may be involved in neural 
membrane functions, such as ion transport, membrane fusion, 
neurotransmitter release, receptor binding and calcium 
homeostasis (Farooqui and Horrocks, 1985). Myelin sheath 
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F i g : - 5,5 
PHOSPHOLIPID 
Cerebrum Cerebellum Brainstem Spinal cord 
Regional alterations in the levels of phospho-
lipids in different regions of rat CNS following 
the administration ©f 3 - p - a c e t o x y - cholest-5-
ene, 3 - p - ocetoxy- 6 - nitro - cholest - 5 - ene, 3-p-
acetoxy-5-C-cholestcn - 5 - ene,- -3 mg/kg body weight 
ip for 15 days. 
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contains 40-45% phospholipids (Fumagelli and Paoletti. 1963). 
The neural nnembranes are highly interactive and dynamic and 
therefore the interaction of ligand with receptor markedly affects 
neural membrane phospholipid metabolism (Loffelholz, 1989). 
This in turn regulates the microenvironment for the activities of the 
• 
membrane bound enzymes and ion channels (Farooqui and 
Horrocks^1985). Porcellati and his Co-workers (1983) reported 
that different phospholipids turnover at different rates with 
respect to their structure and localization in various cells and 
membranes. Newly synthesized phospholipds are transported to 
membrane structure by phospholipid exchange and transfer 
proteins (Brammer, 1983; Demel et al.,1984) which are found in 
cytosol. The distribution of phospholipids in a biologic membrane 
is thus regulated not only by the activities of enzymes involved in 
their metabolism but also by the transport and incorporation 
processes into the membrane. Many investigators such as 
Porcellati et al. (1970 a.b). Ansell and Spanner (1971) and 
Procellti et al. (1971) have concentrated on the regulatory 
mechanisms of phospholipid biosynthesis in the brain and of the 
alternative metabolism pathways involved should be of interest 
113 
because it is highly probable that the metabolism of phospholipids 
in brain is somewhat different from that in other tissues whereas 
Rossiter (1966) had proposed that metabolic pathways of 
phospholipids in brain are similar to those in systemic organs. 
Presently a phospholipid drug glyceryl-phosphoryl-0-serine 
is available in the market, which posses potent behavioral (Favit 
et al.^1993) and neurochemical effects (Deutsch,1971; Breese et 
al.,1978). This drug is being used as a modulator for pituitary 
ACTH and hypothalamic corticotropin releasing hormone 
(Chiarenza, A. et al.,1995) by the physicians. 
Glyceryl-phosphoryl-0-serine (GPS) is a novel drug which 
acts as a precursor of membrane phospholipids participating a 
signal transduction (Casabona et al.,1993). GPS has been shown 
to modulate protein kinase C activity in the central nervous system 
of the aging rat either directly or indirectly (Casabona et al.,1993). 
As per available literature there is no any data available 
based on the studies of cholesterol derivatives on central nervous 
system, so far as studies on primovler (oral contraceptive) steroids 
on central nervous systems by Islam et al. (1981) shows that a 
significant decrease in the level of phospholipid, in hypothalamus, 
hippocampus, midline nuclei of thalamus and gyrus singuli has 
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been consistently observed after 60 and 90 days i.m. 
administration. 
In another study Islam et al. (1981) established that steroid 
contraceptive estrogen decreases the contents of phospholipids 
in amygdaloid nucleus, hippocampus and midline nucleus of 
thalamus. 
In the present study an attempt has been made to evaluate 
the level of phospholipids in CNS, following the ip administration 
of cholesterol derivatives i.e. 3-B-acetoxy-cholest-5-ene, 3-Q>-
acetoxy-6-nitro-cholest-5-ene, 3B-acetoxy-5a-cholestan-6-one , 
in albino rats. 
Present study reveals that maximum effect occurs with the 
acetoxy-nitro derivative in cerebrum where it induces a significant 
depletion of-35.14%. 
Estimation of phospholipids in the cerebellum of the treated 
rats with all the three steroids show its enhanced level. Maximum 
significant rise is 238.03% with the acetoxy-keto derivative and 
with the acetoxy-nitro derivative a significant rise of 184.53% is 
observed. 
In the brain stem, acetoxy-keto and acetoxy derivative 
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increases (141.01% and 22.39%) the phospholipid level but the 
treatment of acetoxy-nitro derivative results In a significant 
depletion in the brain stem. 
Spinal cord shows the, insignificant depletion of 
phospholipids In the treated rat with all the three steroidal 
derivatives. 
Activity trend of 3-fi-acetoxy-cholest-5-ene in the different 
brain parts shows the only significant and maximum rise in 
cerebellum. While in rest of three parts (brain stem, cerebrum and 
spinal cord) a significant depletion (96.58%, 35.14%, 22.77%) in 
the phospholipid level is reported in this study. 
On analysing the activity of acetoxy-keto derivative on 
different parts of the treated rat brain it become clear that a sharp 
and significant enhancement is occurring in cerebellum and brain 
stem (238.035% and 141.10% respectively). Whereas an 
Insignificant depletion in the cerebrum and spinal cord is reported. 
On the comparative study of all the three steroidal 
compounds, facts emerges that acetoxy compound induces 
maximum insignificant rise in the phospholipid level in brain stem 
and maximum insignificant depletion in the spinal cord. 
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Acetoxy-nitro compound induces maximum significant rise 
in the cerebellum and maximum significant depletion in the brain 
stem. Acetoxy-keto compound induces maximum significant rise 
in the cerebellum and maximum insignificant depletion in the 
cerebrum. 
It is an interesting thought, that overall rates of phospholipid 
turnover for the vk^ hole brain might be the sum of very different 
rates of turnover characterizing the turn over rates for phospholipids 
in specific structure, for example in growing cell membranes or in 
changing mitochondrial population. 
5.6 RATE OF LIPID PEROXIDATION : 
Brain contains large amounts of lipids that are rich in 
polyunsaturated fatty acids. The unsaturated bonds of membrane 
lipids can readily react with free radicals and undergo peroxidation 
(Jesberger and Richardson, 1991). Lipid peroxidation has been 
identified as a basic deterloative reaction in the cellular mechanism 
(Tappelj 1973). It is an autocatalytic free radical process. 
Biomembrane and subcellular organelles are the major sites of 
lipid peroxidation Tappel,(1970). Quantitative studies of enzymatic 
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Regional alterations in the levels of rate of 
lipid peroxide formation in different regions of 
rat CNS following the administration of 3 -B-
ocitoxy - cholest - 5 - ene, 3-p - ocetoxy - 6-.nitro-
cholest - 5 ene, 3 - p - ocetoxy- 5 - ^ - choleston • 
6-one, -3 mg kg/body weight ip for 15 days. 
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Inactivation by lipid peroxidation have shown that sulfhydryl 
enzymes are most susceptible to inactivation (Numan et al.^ 1990). 
Each lipid peroxide is also a free radical and once inititated 
the process of peroxidation can become autocatlytic as each lipid 
peroxide products. These lipid peroxides readily decompose to 
<jberate highly reactive carboxyl fragments such as 
malondialdehyde (Tappe. 1973). Malondialdehyde (MDA). X-3-
carbon dialdehyde is one of the final products of free radical chain 
reaction v\/hich takes place during lipid peroxidation (Nomura et al. 
1989). The H^Oj and other reacgive 0^ species if not scavenged 
efficiently are knovk^ n to give rise to potentially toxic Intermdeiates, 
namely hydroxy radical ^OH) and singlet (0^°). These oxidants in 
the presence of metal Ions, result in the formation of lipid 
peroxidation (Lai et al.,1979a). 
Gutteridge (1982) has shown that malondialdehyde is the 
major species responsible for thiobarbituric acid reactive products 
(TBA-RS). Whether the substances undergoing free radical induced 
damage are polyunsaturated fatty acids, amino acids, 
carbohydrates or nycleic acids. Therefore, measurement of 
thiobarbituric acid substance Is one of evaluating the extent of 
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tissue damage due to free radicals. However, the best-induced 
effect of a free radical attack is that causing lipid peroxidation, i.e. 
oxidation of a methylene bridge of unsaturated fatty acids, resulting 
in the formation of lipid peroxides and hydroperoxides, finally 
leading to fragmentation of lipids. As biomembranes are rich in 
unsaturated fatty acis, such reactions may lead to the disintegration 
of membrane structure and finally to Irreversible cell damge 
(Rehncrona et al.^1980). 
Inititation of lipid peroxidation in a membrane or free fatty 
acid is due to the attack of any species that has sufficient reactivity 
to abstract a hydrogen atom. Since a hydrogen atom has only one 
electron, this leaves behind an unpaired electron on the carbon 
at •^ . The carbon radical in a polyunsaturated fatty acid tends to 
be stabilized by a molecular rearrangement to produce a conjugated 
diene, which rapidly reacts with 0^ to give hydroperoxy radical. 
Hydroperoxy radicals abstract hydrogen atoms from other lipid 
molecules, and so contineues the chain reaction of lipid 
peroxidation. The hydroperoxy radical combines with the hydrogen 
atom that it abstracts to give a lipid hydroperoxide (Barber and 
Bernheim, 1967). 
LH = Fatty acids; LOOM = Lipid hydroperoxides, 
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L" = Lipid alkyl radical; LOO" = Lipid peroxy 
radicals (Aust and Svingen. 1982). 
Initiation 
LH + Oj > Free radicals, L° (1) 
LOOM > Free radicals, L00° (2) 
Propagation 
LOO" + L00° > LOO^ 
Termination 
L00° + L00° > LOO + O2 
LOO° + L° >LOOL 
L° +L° >LL 
Oxygen free radical induced oxidative damage has been 
implicated in the aetiology of a number of diseases, including 
atherosclerosis, inflamation, cancer, and ischemia reperfusion 
(Henning and Chow, 1988, Mc Cord 1987; Korumbo et a!.,1985). 
Toxicity of uraemia is due at least in part to oxygen free radicia 
mediated lipid peroxidation and other tissue damaging effects 
(Hassan et aly1995). 
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There is considerable evidence suggesting the involvement 
of free radicals and lipid peroxidation in atherogensesis (Stringer 
et al.,1989. Duthie and Whale,1990; Esterbaner et a|„1990; Gey, 
1990; Oliver^1990). 
In the present study, follov\/ing the administration of acetoxy. 
acetoxy-nitro, acetoxy-keto, derivatives of cholesterol rate of lipid 
peroxidation was estimated. Acetoxy-nitro compound gives a 
significant enhancement in the rate of lipid peroxidation while 
acetoxy and acetoxy-keto derivatives induces more or less similar 
insignificant enhancement in cerebrum of rats brain. 
Effect of these three derivatives on cerebellum shows 
Insignificant depletion in the rate of lipid peroxidation in the 
acetoxy and acetoxy-nitro treated rat brain whereas acetoxy-keto 
derivative results in an insignificant rise in the rate of lipid 
peroxidation in cerebellum. 
The acetoxy derivative treated rat brain stem shows 43.15% 
significant rise in the rate of lipid peroxidation. Acetoxy-keto 
derivative also induces significant rise (35.88%) in the value of 
rate of lipid peroxidation. Acetoxy-nitro derivative is least active 
in brain stem as it exerts only 2.42% insignificant rise in the lipid 
peroxides. 
122 
spinal cord shows insignificant depletion in the lipid 
peroxidation In the acetoxy-keto and acetoxy-nitro treated rat 
brain, while an insignificant rise occurs in the lipid peroxides with 
the acetoxy derivative in spinal cord 
Acetoxy derivative insignificantly deplets the lipid peroxides 
in cerebellum. Maximum significant rise in the lipid peroxides is 
reported In brain stem, whereas in the cerebrum and spinal cord 
only insifnificant enhancement in level of peroxides formation 
occurs. Effect of Acetoxy-nitro derivative on the different parts of 
rat brain shows significant rise in the cerebrum and insignificant 
Increase in the brain stem while in the cerebellum and spinal cord 
an insignificnat depeletion in the lipid peroxidation is reported In 
this study. 
Acetoxy-keto derivative induces significant increase in the 
lipid peroxidation level in the brain stem (35.88%) whereas in 
cerebellum and cerebrum insignificant rise in its values is reported 
In this study. Only spinal cord shows insignificant depletion in the 
rate of lipid peroxidation, induced by acetoxy-keto derivative. 
The acetoxy treated derivative shows maximum activity in 
the brain stem, where 43.15% significant rise is estimated. 
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Maximum significant rise 31.36% is reported with acetoxy-nitro 
derivative in cerebrum. Acetoxy-keto treated rats show maximum 
effect in the brain stem, it induces 35.88% significant rise in the 
lipid peroxidation. 
Increased production of oxygen free radicals and/or unpaired 
antioxidant defense mechansim result in an oxidant-antioxidant 
imbalance with consequent oxidative cellular damage (Sies 
1986a). 
Decreased lipid peroxidation reduces endothelial damage 
and modification of low density lipoprotein (Nafeeza, M. et al. 
1996). 
The increase In the lipid peroxidation process will provide 
abundance of aldehyde products of lipid hydroperoxide break 
down which Is responsible for the modification of low density 
lipoprotein to the oxidized state (Esterbaner et al. 1993). The 
oxidized low density lipoprotein is then endocytosed by the 
macrophages through Its scavenger receptors. The arterial smooth 
muscle cells is also seen to internalized oxidized low density 
lipoprotein thus massive amounts of cholestrol known as foam 
cells accumulates in the macrophages and smooth muscle cells 
(Schffner et al.1980, GerrityJ981; Agnel et al. 1984). 
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5.7 CHLOESTROL/PHOSPHOLIPID (C/P) RATIO : 
Cholesterol and phospholipid ratio Is generally considered 
to be an index of atherogenecity. Cholesterol appears to be 
incorporated into the cells of lesion, esterified with in the cells and 
transformed into amorphous droplets of cholesteryl esters (Weller, 
et al. 1968). Cholesterol is a well known major constituents of 
atherosclerotic lesions (Frantz and Moore, 1969). The 
accumulation of cholesterol in aorta parallels remarkably well 
with the serum cholesterol (Nichols etal. 1971). Furhtermore, the 
presence of lecithin-cholesterol transcacylase in the arterial wall 
provies evidence for the esterification of cholesterol in aorta, 
since only free cholesterol rather than esterified cholesterol is 
exchanged with the blood during atherosclerosis. 
The studies on estrogen and cholesterol induced coronary 
atherosclerosis in cockerels have shown experimental support for 
the hypothesis that elevation of the c/p ratio rather than changes 
in plasma lipid levels Per-se may be a significant factor in 
coronary atherogenesis (Katz and Pick, 1961). Data from 
experiments using rabbits and rats give additional support to this 
possibility. Thus, in rabbits fed an atherogenic diet including 
cholesterol, estrogens failed to prevent th e c/p ratio elevation or 
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to inhibit coronary atherosclerosis (Stanpler, et al. 1956). In the 
rats, on the other hand, Moskowitz, et al (1961) reported that 
although estradiol benzoate administration resulted in elevated 
serum cholesterol and lipid phophorous levels. The c/p ratio v^ as 
depressed toward normal and v\/as associated with inhibitition or 
coronary atherosclerosis. 
After intramuscular administration of 100 ug estrogen daily 
for 30 days to each female rabbit, it was observed that cholesterol/ 
phospholipid ratio increased in cerebellum and decrease in brain 
stem and spinal cord (Islam et al. 1984). 
It was noted during this study that c/p ratio was almost 
decreased in cerebrum, with the administration of 3B-acetoxy-
cholest-5-ene, 3B-acetoxy-6-nitro-cholest-5-ene. 30.-acetoxy-
5a-cholestan-6- one for 15 days i.p. In male albino rats. 
In the cerebellum c/p ratio was decreased with the effect of 
acetoxy derivative of cholesterol. Maximum increase In the ratio 
is reported v^ rtih acetoxy-nitro derivative than acetoxy-keto 
derivative. 
Steroidal derivatives, acetoxy and acetoxy-keto derivative 
deplete the c/p ratio In brain stem while acetoxy-nitro derivative 
enhances the c/p ratio in brain stem. 
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Acetoxy-keto derivative induces, maximum depletion in c/p 
ratio in spinal cord, than comparable to the acetoxy-nitro and 
acetoxy derivative. 
Acetoxy derivative induces maxium depletion in c/p ratio in 
brain stem and minimum in cerebellum. Interestingly acetoxy 
derivative reduces the c/p ratio in all brain parts. 
Acetoxy-nitro derivative whereas deplets the c/p ratio 
maximum in pinal cord, and minimum in cerebrum. Maximum-
increase in the c/p ratio occurs in cerebellum only. 
Acetoxy-keto derivative depletes c/p ratio maximum in spinal 
cord and minimum depletion occur in brain stem, whereas the 
cerebellum only shows the enhanced c/p ratio with the effect of 
acetoxy-keto derivative. 
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